{"meta":{"query_hash":"ac4ca2444aff","filters":{"venue":"Drugs in R&D"},"cohort_total":56,"direct_labels_cover":0,"predictions_cover":56,"exported":56,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ac4ca2444aff","api":"https://metacan.xera.ac/api/v1/cohort?venue=Drugs+in+R%26D"},"results":[{"id":"W139570440","doi":"10.2165/00126839-200607020-00001","title":"Selective Phosphodiesterase (PDE)-4 Inhibitors","year":2006,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Neuroinflammation; Neuroprotection; Phosphodiesterase; Neuroscience; Disease; Medicine; Amyloid (mycology); Cyclic adenosine monophosphate; Microglia; Pharmacology; Alzheimer's disease; Psychology; Internal medicine; Biology; Enzyme; Inflammation; Biochemistry; Pathology; Receptor","score_opus":0.013165600289247858,"score_gpt":0.293421831570008,"score_spread":0.28025623128076016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W139570440","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009266026,0.9907284,0.0015677555,0.0006433896,0.00072019943,0.000028374174,0.00009554163,0.000072699484,0.0052171275],"genre_scores_gemma":[0.004739561,0.98397946,0.0017014598,0.0008344972,0.00033857935,0.000047915913,0.00022403158,0.000010322261,0.008124238],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998882,0.000012143803,0.000010132351,0.000024310164,0.0000467849,0.000018320567],"domain_scores_gemma":[0.9999044,0.000036282854,0.000017486493,0.0000045268243,0.00002132481,0.00001590013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003403818,0.0013178813,0.0015013496,0.0011417283,0.00024747674,0.00060213194,0.0009820987,0.000697934,0.0034621796],"category_scores_gemma":[0.0003349897,0.0002567843,0.00038949985,0.0010553715,0.00043871193,0.00062654103,0.00045463088,0.0018593727,0.0030873267],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017938971,0.00017315148,0.00012145443,0.002831281,0.00007113364,0.0002785316,0.000022383107,0.00038713712,0.006073082,0.0031076581,0.047452074,0.9393028],"study_design_scores_gemma":[0.00013427311,0.00021986448,0.0008419719,0.00052258983,0.000119712226,0.001648975,0.000023559498,0.00020270866,0.003964901,0.0014250914,0.99087477,0.0000215433],"about_ca_topic_score_codex":0.00093437394,"about_ca_topic_score_gemma":0.0029106971,"teacher_disagreement_score":0.0034621796,"about_ca_system_score_codex":0.0006073904,"about_ca_system_score_gemma":0.0005922102,"threshold_uncertainty_score":0.011582077},"labels":[],"label_agreement":null},{"id":"W15991883","doi":"10.2165/00126839-200506040-00006","title":"Is there a Scottish road to socialism","year":2007,"lang":"en","type":"book-chapter","venue":"Drugs in R&D","topic":"Political and Economic history of UK and US","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Socialism; Political science; Economic geography; Geography; History; Law","score_opus":0.0513895762944489,"score_gpt":0.318495621233826,"score_spread":0.2671060449393771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W15991883","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024001494,0.007044979,0.0006838355,0.5694987,0.016045254,0.000025044259,0.0002015782,0.00022869649,0.4038718],"genre_scores_gemma":[0.12065371,0.009533386,0.0013732875,0.2872845,0.009903397,0.000078705394,0.00025711782,0.0006003862,0.57031554],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99355644,0.0022773137,0.00012347991,0.0006558178,0.0015747848,0.0018120822],"domain_scores_gemma":[0.9926604,0.0011088334,0.00036363574,0.0010833647,0.0014518003,0.0033318424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060483157,0.00073053816,0.0007452953,0.0012745156,0.014794454,0.016242748,0.0015223541,0.007327907,0.13207103],"category_scores_gemma":[0.009468685,0.0003069891,0.00074540684,0.0010693576,0.01997323,0.011999524,0.009965117,0.00982619,0.030839527],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003635627,0.000040517523,0.0004525256,0.00005139392,0.000009776007,0.0001634757,0.0037641588,0.000018778446,0.000086753345,0.23433559,0.72114265,0.039898023],"study_design_scores_gemma":[0.000005564255,0.00000994569,0.00024129085,0.00008911133,0.0000016282706,0.000050861,0.0017034506,0.0000111084955,0.000026926373,0.012498539,0.9853526,0.0000090638705],"about_ca_topic_score_codex":0.022015564,"about_ca_topic_score_gemma":0.035523225,"teacher_disagreement_score":0.13207103,"about_ca_system_score_codex":0.0059759775,"about_ca_system_score_gemma":0.008226522,"threshold_uncertainty_score":0.44182163},"labels":[],"label_agreement":null},{"id":"W1976165878","doi":"10.2165/11593140-000000000-00000","title":"Impact of Respiratory Syncytial Virus","year":2011,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Respiratory viral infections research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Jewish General Hospital; Children's Hospital of Winnipeg; Mount Sinai Hospital","funders":"","keywords":"Palivizumab; Medicine; Transmission (telecommunications); Respiratory tract infections; Virus; Intensive care medicine; Disease; Infection control; Pediatrics; Health care; Respiratory system; Immunology; Internal medicine","score_opus":0.16643239077104025,"score_gpt":0.4867733928526308,"score_spread":0.32034100208159055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976165878","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028238152,0.9975076,0.00003214904,0.00017811531,0.00016153787,0.0000039120046,0.000023078393,0.0000031265813,0.0018081008],"genre_scores_gemma":[0.004744413,0.99388254,0.00009885716,0.00023873989,0.0001516007,0.000006820636,0.000060622733,0.000001399356,0.0008149675],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996032,0.00010085745,0.00005645054,0.000046613754,0.00015292066,0.0000399605],"domain_scores_gemma":[0.99949324,0.00027266506,0.00007265505,0.000011307021,0.000114145034,0.000035975056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068576477,0.00075608364,0.0011848661,0.0009480714,0.00018826338,0.00092962134,0.0006550543,0.00094840885,0.004749041],"category_scores_gemma":[0.0012381397,0.00019876822,0.00072509487,0.0007452896,0.00024828478,0.0006436727,0.00057295355,0.000899821,0.0018404111],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013412804,0.000059028527,0.00093884557,0.02289772,0.00029379074,0.00054093904,0.00009097629,0.0002605052,0.0030254368,0.0017633095,0.025146283,0.94484895],"study_design_scores_gemma":[0.000048489805,0.00025853745,0.0056520174,0.00870103,0.00040975382,0.0039114817,0.00013026713,0.00007988908,0.0017606099,0.0009036512,0.97811913,0.00002522407],"about_ca_topic_score_codex":0.0019296877,"about_ca_topic_score_gemma":0.0022975153,"teacher_disagreement_score":0.004749041,"about_ca_system_score_codex":0.0005152269,"about_ca_system_score_gemma":0.0010305076,"threshold_uncertainty_score":0.015887082},"labels":[],"label_agreement":null},{"id":"W1983697728","doi":"10.2165/11596340-000000000-00000","title":"Boosted Tipranavir versus Darunavir in Treatment-Experienced Patients","year":2011,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Boehringer Ingelheim","keywords":"Darunavir; Raltegravir; Ritonavir; Medicine; Maraviroc; Viral load; Regimen; Adverse effect; Internal medicine; Integrase inhibitor; Clinical endpoint; Gastroenterology; Virology; Pharmacology; Randomized controlled trial; Human immunodeficiency virus (HIV); Antiretroviral therapy","score_opus":0.042722759738994726,"score_gpt":0.290875164831624,"score_spread":0.24815240509262929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983697728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924946,0.004480431,0.0002009233,0.00031018394,0.00013828656,0.0002656752,0.00037049208,0.00002170396,0.0017176926],"genre_scores_gemma":[0.9964592,0.0013660664,0.00041646542,0.0004451893,0.00020193723,0.00020657804,0.0003955391,0.0000037965053,0.0005051909],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996257,0.00021451562,0.000033715183,0.000049580754,0.000022883454,0.000053616426],"domain_scores_gemma":[0.9989692,0.0003760405,0.00020487995,0.00005941271,0.000040367613,0.0003502169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011649089,0.0003677427,0.0012432134,0.00013809743,0.00016760192,0.00075637805,0.00035426323,0.0005181872,0.0036136708],"category_scores_gemma":[0.0012817114,0.00021324774,0.0008480263,0.00019514275,0.00032590498,0.0004213242,0.00021524639,0.0013629509,0.00033981132],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9202097,0.004097286,0.00826049,0.00059519353,0.0010883785,0.00011857478,0.00008544834,0.0011625635,0.0035075725,0.00021986228,0.0011422955,0.059512522],"study_design_scores_gemma":[0.697397,0.26700512,0.026817353,0.00017761569,0.0014921159,0.00039926692,0.00008471191,0.002354286,0.001320709,0.00063951797,0.0022808383,0.000031566076],"about_ca_topic_score_codex":0.00023030768,"about_ca_topic_score_gemma":0.0007651002,"teacher_disagreement_score":0.0036136708,"about_ca_system_score_codex":0.00029003862,"about_ca_system_score_gemma":0.000521871,"threshold_uncertainty_score":0.012088954},"labels":[],"label_agreement":null},{"id":"W1990684646","doi":"10.2165/00126839-200506010-00005","title":"Pharmacokinetics and Pilot Efficacy of???a Mesalazine Rectal Gel in Distal Ulcerative Colitis","year":2005,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada); University of Alberta; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Ulcerative colitis; Mesalazine; Medicine; Pharmacokinetics; Gastroenterology; Internal medicine; Pharmacotherapy; Disease","score_opus":0.007117704362962512,"score_gpt":0.26424613722991114,"score_spread":0.25712843286694864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990684646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980509,0.0005667418,0.000410565,0.00011059516,0.000049641258,0.000069865666,0.00019354343,0.000056192475,0.0004918006],"genre_scores_gemma":[0.998643,0.0001735779,0.00036773944,0.000068688954,0.000047876347,0.00003223798,0.00019277615,0.000019100407,0.00045506263],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99938524,0.0003044145,0.00003942207,0.00010067479,0.000063580905,0.00010662958],"domain_scores_gemma":[0.9991905,0.00029183232,0.00011860723,0.00012322572,0.000053248084,0.00022261009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008362648,0.00040798556,0.0010294807,0.00028310897,0.0002284753,0.0007285817,0.00037296608,0.0007286272,0.0014001036],"category_scores_gemma":[0.0018534907,0.00043090878,0.0006950162,0.00020950222,0.00071090134,0.0008903205,0.000187892,0.0016447423,0.0004979854],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72415215,0.016107513,0.006935027,0.00018949357,0.00061966915,0.00036011243,0.0002672753,0.0021173866,0.17995355,0.00028508776,0.0011821411,0.06783067],"study_design_scores_gemma":[0.057520304,0.7041416,0.05715866,0.000028145345,0.0016246497,0.0010093674,0.00024041263,0.010923476,0.16282932,0.00032829263,0.004057741,0.00013803154],"about_ca_topic_score_codex":0.0010249257,"about_ca_topic_score_gemma":0.0006972014,"teacher_disagreement_score":0.0014001036,"about_ca_system_score_codex":0.00041673178,"about_ca_system_score_gemma":0.00037290013,"threshold_uncertainty_score":0.004683852},"labels":[],"label_agreement":null},{"id":"W2002722147","doi":"10.2165/00126839-200607010-00003","title":"A Newly Synthesised Molybdenum/Ascorbic Acid Complex Alleviates Some Effects of Cardiomyopathy in Streptozocin-Induced Diabetic Rats","year":2006,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Vanadium and Halogenation Chemistry","field":"Chemistry","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Allison University","funders":"","keywords":"Ascorbic acid; Streptozocin; Internal medicine; Diabetes mellitus; Endocrinology; Diabetic cardiomyopathy; Medicine; Insulin; Chemistry; Streptozotocin; Heart failure; Cardiomyopathy; Food science","score_opus":0.008430378460796025,"score_gpt":0.2201597351369941,"score_spread":0.21172935667619808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002722147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838997,0.0058010174,0.0083765965,0.00013285298,0.00015198874,0.00005459195,0.00016284785,0.00020836205,0.0012120358],"genre_scores_gemma":[0.99263644,0.0013415538,0.004405925,0.000048194135,0.000027528733,0.000014837996,0.00014249985,0.000018647293,0.0013641943],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994993,0.000007557665,0.0000058332416,0.000014319705,0.000010416068,0.000012002641],"domain_scores_gemma":[0.9999392,0.0000058556134,0.0000182009,0.0000050907206,0.0000076046645,0.000024026245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099938414,0.00031779558,0.00035611223,0.00030772813,0.00017818413,0.00026668172,0.00036514818,0.0003565297,0.0008112357],"category_scores_gemma":[0.00012040793,0.00016299993,0.00015824658,0.0001601141,0.00017691005,0.00019509121,0.00017458595,0.0004619655,0.0001357813],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005440435,0.000047454876,0.00012201964,0.0001270661,0.000023254834,0.000077972305,0.000026013347,0.00010422708,0.9946502,0.00023757735,0.000067675835,0.0039726337],"study_design_scores_gemma":[0.000091897986,0.00064607273,0.00058171054,0.0000071083623,0.00007403545,0.00013716743,0.000009179466,0.00040397744,0.9942259,0.000070685484,0.0037443906,0.000007894103],"about_ca_topic_score_codex":0.0005235648,"about_ca_topic_score_gemma":0.00066258846,"teacher_disagreement_score":0.0008112357,"about_ca_system_score_codex":0.00017722914,"about_ca_system_score_gemma":0.00024504194,"threshold_uncertainty_score":0.0027139187},"labels":[],"label_agreement":null},{"id":"W2011049230","doi":"10.2165/00126839-200809050-00002","title":"Applications of Metabolomics in Drug Discovery and Development","year":2008,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":241,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Genome Alberta","keywords":"Metabolomics; Drug discovery; Drug development; Identification (biology); Biomarker discovery; Pharmaceutical industry; Data science; Computational biology; Drug; Computer science; Biochemical engineering; Medicine; Pharmacology; Bioinformatics; Biology; Proteomics; Engineering","score_opus":0.015038168381594233,"score_gpt":0.28750146908595287,"score_spread":0.27246330070435865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011049230","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014332069,0.9945304,0.0021893317,0.00067111553,0.0004125068,0.00000943979,0.000025489526,0.000027623166,0.001990776],"genre_scores_gemma":[0.0009767977,0.9950722,0.0018892038,0.00044802908,0.00057074154,0.000011441204,0.00003332524,0.0000035339547,0.0009946916],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996132,0.000074546166,0.000026402016,0.00006687713,0.00019326033,0.000025684894],"domain_scores_gemma":[0.9989786,0.00064085424,0.00007609907,0.00004257676,0.00020218348,0.000059715472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014764484,0.0015473593,0.0024748775,0.0030200004,0.00036852254,0.0014447083,0.0015400302,0.0019056494,0.0033259604],"category_scores_gemma":[0.0012243412,0.00049273745,0.00076667813,0.0039991154,0.0012963908,0.002081732,0.001071003,0.0023744612,0.0033100385],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008234518,0.00009205948,0.00022161688,0.0056919055,0.00015011746,0.00023862888,0.00003567412,0.0008662311,0.0050105057,0.009043771,0.027752355,0.9508148],"study_design_scores_gemma":[0.000035683184,0.00013317405,0.0010740153,0.0012830556,0.00012941286,0.0013876918,0.000063718406,0.00058798277,0.0026854083,0.012211421,0.980352,0.000056479596],"about_ca_topic_score_codex":0.0011398026,"about_ca_topic_score_gemma":0.0021668752,"teacher_disagreement_score":0.0033259604,"about_ca_system_score_codex":0.0010933559,"about_ca_system_score_gemma":0.00096128066,"threshold_uncertainty_score":0.011126459},"labels":[],"label_agreement":null},{"id":"W2014795914","doi":"10.1007/s40268-013-0030-8","title":"An In Vitro Analysis of Disintegration Times of Different Formulations of Olanzapine Orodispersible Tablet: A Preliminary Report","year":2013,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Advanced Drug Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); Waypoint Centre for Mental Health Care; University of Toronto","funders":"Eli Lilly and Company","keywords":"Olanzapine; Active ingredient; Dissolution; Excipient; Chromatography; Dosage form; Dissolution testing; Materials science; Pharmacology; Chemistry; Medicine; Biopharmaceutics Classification System; Schizophrenia (object-oriented programming)","score_opus":0.04067849629454533,"score_gpt":0.3935812172620812,"score_spread":0.35290272096753583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014795914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97406685,0.013647014,0.0065663564,0.000105929124,0.00009172133,0.00032461365,0.0021781449,0.000054007218,0.0029653788],"genre_scores_gemma":[0.97069067,0.0057076276,0.017110886,0.00008675477,0.00004849383,0.00020145444,0.0031912285,0.000034559675,0.00292826],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99945384,0.000103543876,0.000108704044,0.00009349522,0.00019095793,0.0000494647],"domain_scores_gemma":[0.9993042,0.00026366874,0.00014479952,0.00004695589,0.00020281298,0.000037502286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007083363,0.00053183903,0.00042590188,0.00039870024,0.00023490726,0.00030783843,0.00022461844,0.00031572,0.0014383572],"category_scores_gemma":[0.0006683038,0.00017690734,0.0006340052,0.00062544324,0.00016846585,0.00026432428,0.00017800208,0.0005033886,0.00032190728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014293802,0.00023430891,0.0021122727,0.00039235465,0.00006879111,0.00014724278,0.00016694119,0.00024214726,0.9856176,0.000054862732,0.0001424431,0.009391755],"study_design_scores_gemma":[0.00010555258,0.010665253,0.031634625,0.000043777854,0.0003874056,0.0007371608,0.00019024558,0.0022184288,0.949617,0.0000432432,0.0043181796,0.00003916777],"about_ca_topic_score_codex":0.0024828517,"about_ca_topic_score_gemma":0.0030366164,"teacher_disagreement_score":0.0024828517,"about_ca_system_score_codex":0.00035997797,"about_ca_system_score_gemma":0.0003945649,"threshold_uncertainty_score":0.0049367547},"labels":[],"label_agreement":null},{"id":"W2015373259","doi":"10.1007/s40268-014-0057-5","title":"Role of Cognitive Enhancer Therapy in Alzheimer’s Disease with Concomitant Cerebral White Matter Disease: Findings from a Long-Term Naturalistic Study","year":2014,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hyperintensity; Medicine; Concomitant; Internal medicine; Cognitive decline; Confounding; Montreal Cognitive Assessment; Stroke (engine); Disease; Retrospective cohort study; Cognition; Pediatrics; Magnetic resonance imaging; Psychiatry; Dementia","score_opus":0.012766708429206216,"score_gpt":0.30807517944199514,"score_spread":0.2953084710127889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015373259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99861073,0.000904784,0.00005843962,0.000053517975,0.0000092145,0.000090912035,0.00006700499,0.0000022475595,0.00020305802],"genre_scores_gemma":[0.9989182,0.00031851805,0.00021434356,0.00012972776,0.000027808663,0.00014117207,0.0001681619,0.0000013218666,0.00008079122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963462,0.0024263794,0.00037866345,0.00032163394,0.00036740612,0.00015983816],"domain_scores_gemma":[0.98835295,0.0046447157,0.00369331,0.0012798904,0.0008941647,0.0011350074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007816928,0.00038734003,0.0011078818,0.00043483646,0.00085416855,0.00080594694,0.0005499953,0.00087633735,0.00083410734],"category_scores_gemma":[0.013589,0.00027299087,0.0018200523,0.00040055742,0.0008453175,0.00082168455,0.0005656632,0.0007026574,0.00017768802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1622858,0.034674253,0.7225999,0.0014033314,0.0054432685,0.00058649346,0.0032561633,0.0003659437,0.0029504066,0.00018294375,0.0006754243,0.06557606],"study_design_scores_gemma":[0.0076850955,0.11815903,0.86790055,0.0002491451,0.0015899464,0.0006980859,0.00079264527,0.0009101978,0.00046236906,0.00022925323,0.0012431655,0.000080408485],"about_ca_topic_score_codex":0.0028775518,"about_ca_topic_score_gemma":0.0040648915,"teacher_disagreement_score":0.007816928,"about_ca_system_score_codex":0.00086415024,"about_ca_system_score_gemma":0.0011390081,"threshold_uncertainty_score":0.04134035},"labels":[],"label_agreement":null},{"id":"W2024058161","doi":"10.2165/11537800-000000000-00000","title":"MicroRNA: Potential Targets for the Development of Novel Drugs?","year":2010,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"microRNA; Biology; Epigenetics; Regulation of gene expression; Gene regulatory network; Gene expression; Translation (biology); Gene silencing; Computational biology; Gene; Messenger RNA; Cell biology; Cancer research; Genetics","score_opus":0.01959533176365454,"score_gpt":0.30339705085268964,"score_spread":0.2838017190890351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024058161","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028835962,0.99083674,0.0010226738,0.0031054714,0.0011353217,0.000015099514,0.000031417643,0.000029482833,0.0035353985],"genre_scores_gemma":[0.0029183105,0.9873964,0.0017847688,0.0022610293,0.0011531468,0.00004323742,0.0000682986,0.000009341131,0.0043654847],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997731,0.00006154284,0.000021227279,0.00004504254,0.00007406505,0.000025074874],"domain_scores_gemma":[0.9998264,0.000062533574,0.000023901386,0.000012290397,0.000042905394,0.000031990912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000828415,0.0009956757,0.0018186071,0.0010600025,0.00032574375,0.0012679585,0.0010223074,0.0022776816,0.0064257],"category_scores_gemma":[0.00062681816,0.00035164086,0.00044655308,0.00089288276,0.0009889939,0.0026735172,0.0007263816,0.0024995985,0.006813218],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019627191,0.00015033915,0.00020999066,0.0047825165,0.000074706295,0.00070177024,0.00011183215,0.0004375634,0.013064812,0.023383979,0.07136838,0.88551784],"study_design_scores_gemma":[0.000046733632,0.00011478654,0.00020572508,0.0005816378,0.00003199412,0.0014072267,0.000049169852,0.00016192901,0.0011997755,0.0069406903,0.9892418,0.000018553013],"about_ca_topic_score_codex":0.00029722956,"about_ca_topic_score_gemma":0.0006532678,"teacher_disagreement_score":0.0064257,"about_ca_system_score_codex":0.00073240494,"about_ca_system_score_gemma":0.0006542179,"threshold_uncertainty_score":0.021496117},"labels":[],"label_agreement":null},{"id":"W2051962629","doi":"10.1007/s40268-015-0082-z","title":"mTOR: A Potential Therapeutic Target in Osteoarthritis?","year":2015,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"PI3K/AKT/mTOR pathway; Osteoarthritis; Cartilage; Medicine; Cancer research; Inflammation; Cell biology; Bioinformatics; Internal medicine; Pathology; Signal transduction; Biology; Anatomy","score_opus":0.02481238498216827,"score_gpt":0.32569452924842207,"score_spread":0.3008821442662538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051962629","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016502876,0.9978241,0.00010749958,0.0005205812,0.00021609204,0.0000049288733,0.000022651593,0.000009611856,0.001129623],"genre_scores_gemma":[0.00091072515,0.997593,0.0001672482,0.00029350148,0.00016620973,0.0000076142205,0.00003657385,0.0000018473111,0.0008232767],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989235,0.000017166343,0.00001556075,0.00002161029,0.00003780359,0.000015499716],"domain_scores_gemma":[0.99991536,0.000027101914,0.000013821923,0.0000028383538,0.000026202026,0.000014674725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029011216,0.00065443496,0.0012213355,0.0014459973,0.00029789397,0.00092912687,0.0007189096,0.0011406151,0.0040412736],"category_scores_gemma":[0.00031708257,0.0002019497,0.00038596406,0.0014064709,0.00045067095,0.001172091,0.00065202126,0.001986576,0.0029877096],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001306408,0.000081265374,0.0001305348,0.010975713,0.000086259635,0.0003237445,0.00006124932,0.0002575935,0.004023277,0.0058185854,0.041296124,0.9368149],"study_design_scores_gemma":[0.000027023412,0.000119939854,0.00042753437,0.0013912274,0.00007954023,0.0013374027,0.000044678403,0.00008632298,0.0007001781,0.0021565799,0.9936133,0.00001635396],"about_ca_topic_score_codex":0.0006088414,"about_ca_topic_score_gemma":0.00145212,"teacher_disagreement_score":0.0040412736,"about_ca_system_score_codex":0.00045465838,"about_ca_system_score_gemma":0.0006506361,"threshold_uncertainty_score":0.013519466},"labels":[],"label_agreement":null},{"id":"W2072492830","doi":"10.2165/00126839-200809030-00001","title":"A Review of the Role of CpG Oligodeoxynucleotides as Toll-Like Receptor 9 Agonists in Prophylactic and Therapeutic Vaccine Development in Infectious Diseases","year":2008,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; CpG Oligodeoxynucleotide; Toll-like receptor; Immunology; DNA vaccination; Pharmacology; Immune system; Biology; Innate immune system; Immunization; Gene; Genetics","score_opus":0.008426552575936072,"score_gpt":0.2615718066041785,"score_spread":0.25314525402824245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072492830","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011893425,0.9983039,0.00018673674,0.00015479913,0.00046321683,0.000007283348,0.000025293311,0.000007896746,0.00073195883],"genre_scores_gemma":[0.0004664074,0.9976683,0.0003459985,0.00026427268,0.00031266114,0.000008395606,0.000046642363,0.0000017694355,0.0008854293],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998394,0.000025834805,0.000030578467,0.000024656469,0.00006465478,0.000014846833],"domain_scores_gemma":[0.99973124,0.00011004491,0.000047995713,0.000006482431,0.00007512502,0.000029056842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005544315,0.00093834626,0.0016716621,0.0021329375,0.00022686485,0.0007730426,0.0010156565,0.0009386064,0.0037834009],"category_scores_gemma":[0.00059647,0.00031297575,0.00041940372,0.00243348,0.00030443445,0.0012349124,0.00048465503,0.0014041789,0.0025165682],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015932422,0.00009391133,0.00009019968,0.018478569,0.00008903072,0.00028783907,0.000034221088,0.00028268123,0.004672958,0.0014936832,0.057285767,0.9170318],"study_design_scores_gemma":[0.000039123555,0.0001544284,0.00048558242,0.0021173859,0.000116018695,0.0011966203,0.000027061717,0.0000858733,0.00089700194,0.0005968311,0.9942648,0.000019279662],"about_ca_topic_score_codex":0.0008581268,"about_ca_topic_score_gemma":0.0020871547,"teacher_disagreement_score":0.0037834009,"about_ca_system_score_codex":0.0004779698,"about_ca_system_score_gemma":0.00083145726,"threshold_uncertainty_score":0.012656748},"labels":[],"label_agreement":null},{"id":"W2079921819","doi":"10.2165/00126839-200607020-00006","title":"Effect of a Novel Molybdenum Ascorbate Complex on Ex Vivo Myocardial Performance in Chemical??Diabetes Mellitus","year":2006,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Vanadium and Halogenation Chemistry","field":"Chemistry","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Allison University","funders":"","keywords":"Diabetes mellitus; Medicine; Internal medicine; Streptozotocin; Endocrinology; Cardiac function curve; Insulin; Heart failure; Cardiology","score_opus":0.007668220954864185,"score_gpt":0.22993033327948179,"score_spread":0.2222621123246176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079921819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975539,0.0009763933,0.00076770206,0.00010195168,0.00007207772,0.000026855245,0.00008821003,0.000038091617,0.00037486097],"genre_scores_gemma":[0.9979971,0.00039467984,0.0006685232,0.0000755192,0.00002176945,0.000013300864,0.00015551763,0.000021318852,0.00065234845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998223,0.0000466945,0.000019320833,0.000040695442,0.000017663264,0.000053312757],"domain_scores_gemma":[0.99978524,0.00006890597,0.000038383892,0.00002779996,0.000022863655,0.00005680979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040493498,0.00035188484,0.0007203975,0.0001324935,0.00026781863,0.00055722083,0.00065778877,0.0007642854,0.0020033477],"category_scores_gemma":[0.000443917,0.00027705613,0.00025160937,0.00019917211,0.00035216322,0.00034493313,0.0002682743,0.00068600045,0.00021767846],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022555223,0.0003935341,0.0003598967,0.00018108482,0.000109842505,0.00009971892,0.000077883684,0.00023123296,0.97289383,0.00025358557,0.0002116121,0.0026326778],"study_design_scores_gemma":[0.0009204746,0.0029992757,0.0010306437,0.000012115747,0.00011707578,0.00011247499,0.000032616077,0.0011466809,0.99226004,0.000054891414,0.0012997222,0.000013857457],"about_ca_topic_score_codex":0.0011579815,"about_ca_topic_score_gemma":0.00085416855,"teacher_disagreement_score":0.0020033477,"about_ca_system_score_codex":0.00028955564,"about_ca_system_score_gemma":0.0003560752,"threshold_uncertainty_score":0.006701827},"labels":[],"label_agreement":null},{"id":"W2083411973","doi":"10.2165/00126839-200607020-00005","title":"Gut Transport of a Molybdenum/Ascorbic Acid Complex","year":2006,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Chromium effects and bioremediation","field":"Environmental Science","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Allison University","funders":"","keywords":"Molybdenum; Ascorbic acid; Small intestine; Incubation; Biochemistry; Chemistry; Biophysics; Biology; Inorganic chemistry; Food science","score_opus":0.00581913416401765,"score_gpt":0.2082372168515531,"score_spread":0.20241808268753547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083411973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927106,0.0023784686,0.0024189407,0.00030076338,0.00013155439,0.000029953437,0.0001477727,0.00008979927,0.0017921077],"genre_scores_gemma":[0.99183273,0.00053828995,0.0022908268,0.000051799158,0.000032565706,0.000007715178,0.00014623637,0.000028330593,0.0050714985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983037,0.000028717988,0.000005270863,0.0000516209,0.0000188214,0.00006520752],"domain_scores_gemma":[0.9998429,0.000038555092,0.00003419442,0.00001773611,0.000019497278,0.000047052767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026629094,0.0002972381,0.00037604143,0.00020242819,0.0002905697,0.0010217086,0.00031249155,0.0006630819,0.0021807721],"category_scores_gemma":[0.0003163464,0.00021122937,0.00034810213,0.00013677707,0.00033182293,0.00041728994,0.00029534742,0.0007957447,0.0003745629],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025794578,0.000049602775,0.00037547536,0.00013448398,0.000031137217,0.0001314084,0.00010523042,0.00013576567,0.9898136,0.0008655074,0.00024158295,0.0055367043],"study_design_scores_gemma":[0.00022814849,0.0017948186,0.0022452367,0.000025617748,0.000115169154,0.0003503647,0.00015624438,0.0035673643,0.98481053,0.00014032048,0.0065460773,0.00002015556],"about_ca_topic_score_codex":0.002759039,"about_ca_topic_score_gemma":0.0024409739,"teacher_disagreement_score":0.002759039,"about_ca_system_score_codex":0.0010825503,"about_ca_system_score_gemma":0.0006244837,"threshold_uncertainty_score":0.007854521},"labels":[],"label_agreement":null},{"id":"W2117988243","doi":"10.2165/11593390-000000000-00000","title":"Impact of Intravenous Naltrexone on Intravenous Morphine-Induced High, Drug Liking, and Euphoric Effects in Experienced, Nondependent Male Opioid Users","year":2011,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"Shionogi; Astellas Pharma; Purdue University; Eisai; Bayer HealthCare; Boston Scientific Corporation; Purdue Pharma; Gilead Sciences; GlaxoSmithKline; Nevro; Teva Pharmaceutical Industries; AstraZeneca; Pfizer","keywords":"Euphoriant; Naltrexone; Morphine; Medicine; Heroin; Opioid; Anesthesia; Narcotic antagonist; Visual analogue scale; Pharmacology; Drug; Internal medicine; Psychiatry","score_opus":0.0124207090589173,"score_gpt":0.26841392998418573,"score_spread":0.25599322092526844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117988243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997205,0.00006499606,0.000021950302,0.000005926986,0.0000030317094,0.000034711768,0.000022141077,0.000002250785,0.00012450978],"genre_scores_gemma":[0.99951804,0.000084097876,0.0001378998,0.000028918517,0.000009224553,0.000034781075,0.000043915392,0.0000011424314,0.00014200014],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99953735,0.0002449206,0.000043264215,0.00004521425,0.00008218708,0.000047018028],"domain_scores_gemma":[0.99905175,0.00038517913,0.0002460529,0.00004798844,0.000041878702,0.0002271424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005530039,0.0002542439,0.00034664865,0.00011302337,0.00012439593,0.00025466408,0.00019618247,0.0002518196,0.001829649],"category_scores_gemma":[0.0020641664,0.0001692769,0.00034763766,0.00008427685,0.0002709228,0.0002488984,0.00017891295,0.00041899676,0.00012290818],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45217234,0.089925766,0.11810683,0.0012340182,0.0012590605,0.0005012296,0.0005786,0.001536153,0.18104589,0.00012201202,0.00035075593,0.15316735],"study_design_scores_gemma":[0.013724641,0.6624467,0.30847478,0.000034327408,0.00032228418,0.00038846393,0.00019552335,0.0013333603,0.012592336,0.000035772115,0.00042548697,0.000026348042],"about_ca_topic_score_codex":0.00032494447,"about_ca_topic_score_gemma":0.0006510464,"teacher_disagreement_score":0.001829649,"about_ca_system_score_codex":0.00018425798,"about_ca_system_score_gemma":0.00017744118,"threshold_uncertainty_score":0.006120801},"labels":[],"label_agreement":null},{"id":"W2160030763","doi":"10.1007/s40268-014-0044-x","title":"Bioequivalence Study of Two Formulations of Ibandronic Acid 150-mg Film-Coated Tablets in Healthy Volunteers Under Fasting Conditions: A Randomized, Open-Label, Three-Way, Reference-Replicated Crossover Study","year":2014,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Bioequivalence; Crossover study; Confidence interval; Pharmacokinetics; Chromatography; Dosing; Bioavailability; Medicine; Chemistry; Pharmacology; Internal medicine","score_opus":0.06410950267279548,"score_gpt":0.3873579237050685,"score_spread":0.323248421032273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160030763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961378,0.00076663424,0.0009738294,0.000038066322,0.00010877801,0.0014362162,0.00022564361,0.000044215816,0.00026881867],"genre_scores_gemma":[0.9929161,0.00051625253,0.0033451684,0.0001804452,0.00014079675,0.0017431877,0.00035804097,0.000020166539,0.00077984383],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978326,0.0010789569,0.00016433567,0.0004706792,0.00034084445,0.00011253339],"domain_scores_gemma":[0.99882835,0.00023654767,0.00031848095,0.00022369798,0.0001773283,0.0002155587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030116632,0.0010585523,0.0026655989,0.0004510571,0.0004486867,0.0007107496,0.00066134566,0.0015937103,0.002290623],"category_scores_gemma":[0.0027598264,0.0007549069,0.0011691054,0.00036141204,0.0009910832,0.0007850219,0.0002785826,0.00093563716,0.0005815463],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8332382,0.031665467,0.0026549788,0.0009244045,0.0010674788,0.00007448085,0.0004269335,0.0005003034,0.10215301,0.00016403213,0.0003986766,0.026732052],"study_design_scores_gemma":[0.16021796,0.80082136,0.02121304,0.000035266472,0.0010416035,0.00014860589,0.000111928144,0.0016053048,0.013398173,0.000117282696,0.0012053361,0.000084014384],"about_ca_topic_score_codex":0.0005856834,"about_ca_topic_score_gemma":0.0004914822,"teacher_disagreement_score":0.0030116632,"about_ca_system_score_codex":0.00039004776,"about_ca_system_score_gemma":0.0006907063,"threshold_uncertainty_score":0.015927374},"labels":[],"label_agreement":null},{"id":"W2520135767","doi":"10.1007/s40268-016-0142-z","title":"Safety of Mebendazole Use During Lactation: A Case Series Report","year":2016,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Breastfeeding Practices and Influences","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"","keywords":"Mebendazole; Breastfeeding; Medicine; Adverse effect; Lactation; Irritability; Pediatrics; Obstetrics; Pregnancy; Internal medicine; Anxiety; Psychiatry; Biology","score_opus":0.021021296830093232,"score_gpt":0.2973752522973009,"score_spread":0.27635395546720765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520135767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98062474,0.008791742,0.0019885506,0.0024136812,0.0002966405,0.00011150146,0.00013489183,0.00009349977,0.0055446574],"genre_scores_gemma":[0.99556005,0.00190816,0.00045479598,0.00060885743,0.000513097,0.000026028725,0.000058932732,0.000013629736,0.0008563646],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99871397,0.00022187713,0.00018816107,0.0002882338,0.0002543174,0.00033347684],"domain_scores_gemma":[0.99634403,0.001050338,0.0013167345,0.0003411957,0.00018803599,0.0007597295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056933623,0.0016681976,0.0013547867,0.0022035816,0.002643919,0.0014939713,0.0012023745,0.004361906,0.0024402763],"category_scores_gemma":[0.004096856,0.00095075986,0.0014176104,0.0013897722,0.0019025772,0.0015642942,0.0016556076,0.002650275,0.0009925781],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055804772,0.00010429791,0.025809748,0.000041011328,0.000020618743,0.9707647,0.0003587866,0.00003790751,0.0006188385,0.00008523766,0.00023965459,0.0018634342],"study_design_scores_gemma":[0.00000896814,0.00011693342,0.006910959,0.000017597222,0.000019903977,0.9917579,0.0002640597,0.00010667796,0.00026814538,0.00005862749,0.0004590521,0.000011079151],"about_ca_topic_score_codex":0.0019738334,"about_ca_topic_score_gemma":0.0020179716,"teacher_disagreement_score":0.004361906,"about_ca_system_score_codex":0.0012998341,"about_ca_system_score_gemma":0.0011754922,"threshold_uncertainty_score":0.009430945},"labels":[],"label_agreement":null},{"id":"W2530554915","doi":"10.1007/s40268-016-0145-9","title":"Bioequivalence and Pharmacokinetic Evaluation Study of Acetaminophen vs. Acetaminophen Plus Caffeine Tablets in Healthy Mexican Volunteers","year":2016,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fraser Health","funders":"","keywords":"Bioequivalence; Acetaminophen; Medicine; Pharmacokinetics; Caffeine; Pharmacology; Immediate release; Internal medicine","score_opus":0.12560134980769763,"score_gpt":0.43794328977569874,"score_spread":0.3123419399680011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530554915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985065,0.00046577843,0.00035543233,0.00003485503,0.000020887916,0.00027451842,0.00008182856,0.000009906674,0.00025049783],"genre_scores_gemma":[0.99779797,0.00030384032,0.0008431968,0.00013856683,0.000051615454,0.00026839296,0.00013587724,0.0000050722383,0.00045551237],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992416,0.00038697897,0.00005055976,0.0001312256,0.0001504047,0.00003932246],"domain_scores_gemma":[0.9993932,0.00010514792,0.00026259356,0.00006497136,0.00007907101,0.000094935174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014417191,0.00054011145,0.00078729447,0.00020389672,0.0003425546,0.00036286964,0.0002585743,0.0006355655,0.0013821779],"category_scores_gemma":[0.0017689377,0.0002685402,0.00036663064,0.00022430107,0.00050664536,0.0003431724,0.00018638831,0.00049084355,0.00026844625],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67461795,0.034436587,0.0327939,0.0009793597,0.0017702958,0.0002594233,0.0007523344,0.0008963588,0.1744741,0.00025035648,0.000723049,0.07804631],"study_design_scores_gemma":[0.04673364,0.7704797,0.1534027,0.000041006035,0.0016440902,0.0005810815,0.00033083442,0.0024778827,0.02109845,0.000102673155,0.003051521,0.000056486904],"about_ca_topic_score_codex":0.0005023784,"about_ca_topic_score_gemma":0.00041458756,"teacher_disagreement_score":0.0014417191,"about_ca_system_score_codex":0.00020790749,"about_ca_system_score_gemma":0.0003444666,"threshold_uncertainty_score":0.007624626},"labels":[],"label_agreement":null},{"id":"W2556835195","doi":"10.1007/s40268-016-0153-9","title":"A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI","year":2016,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":342,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; McGill University","funders":"","keywords":"Sialorrhea; Salivary gland; Medicine; Oral medicine; Dentistry; Dermatology; Internal medicine; Surgery","score_opus":0.0271903309366712,"score_gpt":0.3502844291157385,"score_spread":0.32309409817906726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556835195","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00070950866,0.96958655,0.002243973,0.00534868,0.001149325,0.011181022,0.0080983015,0.00015972822,0.001522994],"genre_scores_gemma":[0.0047256886,0.9405198,0.019379538,0.005895177,0.00041167194,0.021436807,0.0049221697,0.000045806588,0.0026633944],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99159557,0.0025406699,0.0039343443,0.0005403178,0.0011858831,0.00020323934],"domain_scores_gemma":[0.9804984,0.010742336,0.0045497147,0.0003506952,0.003465323,0.00039360064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012566421,0.002206451,0.007974366,0.03424787,0.0011066947,0.0033855045,0.0033043863,0.0022573092,0.01904657],"category_scores_gemma":[0.031747144,0.0017678149,0.00836009,0.022388464,0.0009577678,0.00545406,0.0026980399,0.0020303417,0.0022359393],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016170318,0.000035047018,0.00088367006,0.869395,0.0020625088,0.00017060083,0.00034652572,0.00020590717,0.000420615,0.0009583914,0.040972415,0.0843876],"study_design_scores_gemma":[0.00032071755,0.00013810277,0.0031566147,0.87903535,0.0067173634,0.00045998694,0.0003393475,0.00023463505,0.000132072,0.0012654063,0.10813352,0.000066986446],"about_ca_topic_score_codex":0.012370012,"about_ca_topic_score_gemma":0.037789468,"teacher_disagreement_score":0.03424787,"about_ca_system_score_codex":0.0068067578,"about_ca_system_score_gemma":0.024827663,"threshold_uncertainty_score":0.066458344},"labels":[],"label_agreement":null},{"id":"W2579057398","doi":"10.1007/s40268-017-0173-0","title":"A Review of Clinical Outcomes Associated with Two Meropenem Dosing Strategies","year":2017,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Meropenem; Dosing; Medicine; Intensive care medicine; Regimen; MEDLINE; Carbapenem; Neutropenia; Internal medicine; Antibiotics; Chemotherapy","score_opus":0.23682066272691937,"score_gpt":0.5424964920427081,"score_spread":0.30567582931578874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579057398","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018716829,0.99947137,0.000023858813,0.00005713626,0.00003974412,0.000013338042,0.000035426336,0.0000021152046,0.00016992938],"genre_scores_gemma":[0.0010114524,0.99867684,0.00010140399,0.00007836162,0.000031766293,0.000018722214,0.000036017802,7.8903406e-7,0.000044641354],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9980248,0.00040567285,0.00090259896,0.00018952695,0.00040735616,0.000069946036],"domain_scores_gemma":[0.99556196,0.0030399906,0.0007755151,0.000059982623,0.0004890061,0.00007369487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019252581,0.0011525495,0.0035228294,0.007865193,0.00041149333,0.00147887,0.0014405991,0.001085952,0.0032453216],"category_scores_gemma":[0.006629308,0.0005496382,0.0027839695,0.008710836,0.000535351,0.0015046556,0.0007750161,0.0008138674,0.00039530697],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025250242,0.0000639154,0.0005685318,0.5868801,0.0014816208,0.00023440579,0.00021332217,0.00020466198,0.0005113989,0.0006666436,0.0076269098,0.40129596],"study_design_scores_gemma":[0.00020998875,0.0008502761,0.011373483,0.6088481,0.020008078,0.004977246,0.00066601636,0.00019761849,0.0009800142,0.0010513826,0.35072863,0.00010914945],"about_ca_topic_score_codex":0.002752945,"about_ca_topic_score_gemma":0.0047194017,"teacher_disagreement_score":0.007865193,"about_ca_system_score_codex":0.0015069677,"about_ca_system_score_gemma":0.0037156085,"threshold_uncertainty_score":0.010933876},"labels":[],"label_agreement":null},{"id":"W2603821422","doi":"10.1007/s40268-017-0180-1","title":"Revisiting CDK Inhibitors for Treatment of Glioblastoma Multiforme","year":2017,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"Canadian Cancer Society Research Institute","keywords":"Cyclin-dependent kinase; Glioma; Glioblastoma; Repurposing; Disease; Medicine; Population; Biology; Bioinformatics; Cancer research; Cancer; Cell cycle; Internal medicine","score_opus":0.08373018955416103,"score_gpt":0.4042266653883339,"score_spread":0.32049647583417284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603821422","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002292898,0.9979868,0.00010313791,0.00032889226,0.00017466553,0.000007380039,0.00002101832,0.0000079906295,0.0011407614],"genre_scores_gemma":[0.001063579,0.9977552,0.00017010221,0.00028242308,0.000109775145,0.00000743404,0.000035433568,0.0000018436513,0.0005741185],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983287,0.000031164007,0.000028915822,0.000028626951,0.000059432383,0.000018880883],"domain_scores_gemma":[0.99982846,0.000082816296,0.000027646598,0.0000045069464,0.000042748237,0.0000137353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054625643,0.0006741741,0.0010850256,0.00202906,0.00024871883,0.0008476541,0.0008735978,0.00077993074,0.0029589366],"category_scores_gemma":[0.0005006178,0.0002975335,0.0006290016,0.001325263,0.00040206377,0.0013582485,0.00056452886,0.0021780396,0.0015983408],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009609263,0.00009164423,0.00013454576,0.013949073,0.000104666295,0.00028883558,0.00007317952,0.00043394393,0.0022023455,0.0040002894,0.02349228,0.9551331],"study_design_scores_gemma":[0.000045586425,0.00015392361,0.0005477588,0.0027887744,0.00011934677,0.0012151692,0.00004993171,0.00015481324,0.00077432976,0.0018754273,0.99226016,0.000014683985],"about_ca_topic_score_codex":0.0010520503,"about_ca_topic_score_gemma":0.003514206,"teacher_disagreement_score":0.0029589366,"about_ca_system_score_codex":0.00058042735,"about_ca_system_score_gemma":0.0007970527,"threshold_uncertainty_score":0.009898603},"labels":[],"label_agreement":null},{"id":"W2620644176","doi":"10.1007/s40268-017-0186-8","title":"Comparison of Generic Drug Reviews for Marketing Authorization between Japan and Canada","year":2017,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Pharmacy and Medical Practices","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"","keywords":"Marketing authorization; Authorization; Drug; Business; Prior authorization; Medicine; Pharmacology; Computer science; Computer security","score_opus":0.25917852282506304,"score_gpt":0.5329395756676412,"score_spread":0.2737610528425781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620644176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6313743,0.24319161,0.0012905059,0.010174103,0.0006642746,0.00083042966,0.028513148,0.00019774363,0.083763875],"genre_scores_gemma":[0.9197019,0.062211175,0.0014753841,0.0034070986,0.00016393016,0.0001700376,0.0063298787,0.00007361228,0.0064670234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9906261,0.0010776576,0.0013924488,0.0008606621,0.004894768,0.0011484083],"domain_scores_gemma":[0.9348993,0.008070971,0.013067364,0.00060677616,0.039465655,0.0038900357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004167489,0.00041379276,0.0006132623,0.011235086,0.0015448454,0.0035305258,0.00067135296,0.0005617646,0.0031309293],"category_scores_gemma":[0.026414651,0.0002416059,0.0008476102,0.017565303,0.00070078595,0.0009071447,0.0009307235,0.0005130011,0.00024482733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023475792,0.0001208354,0.6331846,0.015136926,0.0015670861,0.0020188098,0.009094144,0.000632682,0.0035302306,0.005700612,0.06132867,0.26533788],"study_design_scores_gemma":[0.000051694155,0.00010951107,0.91089344,0.001871036,0.00081035495,0.000694107,0.005770911,0.00032730092,0.0009230991,0.000116769756,0.078358196,0.00007347277],"about_ca_topic_score_codex":0.8550679,"about_ca_topic_score_gemma":0.93397003,"teacher_disagreement_score":0.14493209,"about_ca_system_score_codex":0.02941179,"about_ca_system_score_gemma":0.056638103,"threshold_uncertainty_score":0.2915712},"labels":[],"label_agreement":null},{"id":"W2736936940","doi":"10.1007/s40268-017-0195-7","title":"Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region","year":2017,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"CYP2C19; CYP2C9; Pharmacogenomics; Genotyping; Phenytoin; Genotype; Medicine; Pharmacogenetics; Pharmacokinetics; Allele; Middle East; Genetics; Pharmacology; Epilepsy; Biology; Geography; Gene; Psychiatry","score_opus":0.48975655035397786,"score_gpt":0.5137854583330572,"score_spread":0.02402890797907936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736936940","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02408425,0.9743858,0.00009136638,0.00044365122,0.00004493166,0.00005128201,0.00044831034,0.000002347827,0.00044809066],"genre_scores_gemma":[0.37071216,0.62684757,0.00069945527,0.0007886125,0.00011179859,0.00019063213,0.00053862744,0.0000046464324,0.000106458116],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99614894,0.0015491736,0.0012736181,0.00037666198,0.00048668295,0.0001650069],"domain_scores_gemma":[0.9849508,0.010482586,0.0036617627,0.00016690447,0.0006294876,0.00010851923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039088503,0.0005205736,0.0026371127,0.0030182838,0.0002966891,0.0011784817,0.0007040684,0.0007863715,0.0014455362],"category_scores_gemma":[0.019368194,0.00030057106,0.0029437027,0.004226535,0.00038802595,0.0008395051,0.0005592747,0.00043988903,0.00007072602],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018044771,0.00005930504,0.10017442,0.6995077,0.0681951,0.0012390073,0.0010664361,0.0006007603,0.0011056877,0.0007125008,0.002416348,0.12311827],"study_design_scores_gemma":[0.00085319474,0.0006030716,0.3070052,0.43565235,0.223253,0.0035221484,0.0016159585,0.00036039014,0.00092213607,0.0010598022,0.025053848,0.00009885964],"about_ca_topic_score_codex":0.008172783,"about_ca_topic_score_gemma":0.014970111,"teacher_disagreement_score":0.008172783,"about_ca_system_score_codex":0.0009196242,"about_ca_system_score_gemma":0.0025409637,"threshold_uncertainty_score":0.020672262},"labels":[],"label_agreement":null},{"id":"W2749649169","doi":"10.1007/s40268-017-0201-0","title":"Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial","year":2017,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Body Composition Measurement Techniques","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"AbbVie","keywords":"Medicine; Placebo; Urology; Internal medicine; Diabetes mellitus; Population; Diabetic nephropathy; Adverse effect; Anesthesia; Endocrinology; Pathology","score_opus":0.031882359487948354,"score_gpt":0.3793242938575151,"score_spread":0.3474419343695667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749649169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865789,0.0069696135,0.00065427955,0.00051925745,0.0007149581,0.0029832113,0.00057566277,0.00012596506,0.00087816565],"genre_scores_gemma":[0.98676366,0.0033286584,0.0019186176,0.00084796554,0.0006947812,0.0045186677,0.0005106296,0.000016672322,0.0014004181],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99881184,0.0006442582,0.00010131657,0.0002200205,0.00008347452,0.00013905452],"domain_scores_gemma":[0.99803394,0.0004713081,0.0005573812,0.0001724303,0.00018625642,0.0005786304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027609328,0.0015901771,0.004002583,0.0004478372,0.0006839729,0.001093518,0.0010405722,0.0025363115,0.004158613],"category_scores_gemma":[0.002765821,0.0008314846,0.001988992,0.00043841073,0.0011517319,0.0009922439,0.0004161228,0.0026733887,0.0005784142],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.990651,0.0036856637,0.00035706055,0.00028270285,0.00051058474,0.000013870127,0.000014516511,0.000059505433,0.0010087811,0.00001639877,0.00012146705,0.00327833],"study_design_scores_gemma":[0.9453526,0.052305225,0.0012669911,0.00002393067,0.00043710382,0.000010705756,0.0000084392395,0.00017752408,0.00024389042,0.000033064633,0.00013186305,0.000008574934],"about_ca_topic_score_codex":0.0009113173,"about_ca_topic_score_gemma":0.0013923715,"teacher_disagreement_score":0.004158613,"about_ca_system_score_codex":0.0005869514,"about_ca_system_score_gemma":0.0014116524,"threshold_uncertainty_score":0.01460135},"labels":[],"label_agreement":null},{"id":"W2751648725","doi":"10.1007/s40268-017-0207-7","title":"Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research","year":2017,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":360,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Benzodiazepine; Adverse effect; Intensive care medicine; Dementia; Psychiatry; Harm; Disease; Pharmacology; Psychology; Internal medicine","score_opus":0.6375684566135268,"score_gpt":0.6246672980506429,"score_spread":0.012901158562883874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751648725","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009357765,0.9994062,0.000038341575,0.00017115628,0.00009558916,0.0000064675437,0.000058520207,0.000002920521,0.00012731511],"genre_scores_gemma":[0.0004718704,0.99908555,0.00013120798,0.00012744394,0.000081192375,0.000006881773,0.000047845107,9.027162e-7,0.000046985435],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99811053,0.0003837846,0.00078109786,0.00020578096,0.00045739592,0.00006143171],"domain_scores_gemma":[0.9938725,0.0037389956,0.001354507,0.00009466229,0.000841303,0.00009801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028021298,0.0012087604,0.0027436074,0.008919439,0.00032533347,0.0013494489,0.0011918094,0.00092661433,0.0035768864],"category_scores_gemma":[0.0066880663,0.0005335156,0.0024952425,0.010308125,0.0005861067,0.0016468153,0.0009896095,0.0012765287,0.00046167913],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015365814,0.000052382005,0.0019661237,0.27043596,0.0015955003,0.0002052948,0.0002543681,0.00027720624,0.00042054235,0.0015341779,0.025090367,0.6980144],"study_design_scores_gemma":[0.000086568194,0.0002604861,0.01706264,0.2416035,0.00801697,0.003188091,0.00049847737,0.00017863924,0.0003944898,0.0020279086,0.72657466,0.000107661705],"about_ca_topic_score_codex":0.003945639,"about_ca_topic_score_gemma":0.00826671,"teacher_disagreement_score":0.008919439,"about_ca_system_score_codex":0.0012307579,"about_ca_system_score_gemma":0.0037290053,"threshold_uncertainty_score":0.014819264},"labels":[],"label_agreement":null},{"id":"W27770296","doi":"10.1007/s40268-016-0139-7","title":"Types of Support Accessed by Families of Young Children with Disabilities Living in Alberta.","year":2004,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Family and Disability Support Research","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychology; Sample (material); Family income; Gerontology; Developmental psychology; Medicine; Economic growth","score_opus":0.01601996718566453,"score_gpt":0.3137259607633713,"score_spread":0.2977059935777068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W27770296","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19009577,0.011288008,0.00053279643,0.01305727,0.001843417,0.00062788045,0.059833735,0.0005086278,0.72221243],"genre_scores_gemma":[0.4712494,0.02045878,0.0031261537,0.007893126,0.00058777607,0.0012210862,0.027213672,0.00019899127,0.468051],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9996474,0.000049918166,0.000020747462,0.000033759094,0.000090643145,0.00015749817],"domain_scores_gemma":[0.99864846,0.00016139967,0.00014372705,0.000044266337,0.00028952814,0.000712656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032481004,0.00030017676,0.0002723633,0.00067652273,0.0029375693,0.0008056425,0.00095129537,0.0005493433,0.2213711],"category_scores_gemma":[0.002644759,0.000115560215,0.0003562623,0.0016779166,0.0002136839,0.0006688993,0.0018173202,0.0004951804,0.019265948],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018036684,0.00017737791,0.06707769,0.0009729389,0.000037006103,0.0034733464,0.0041124676,0.00008447321,0.0002578506,0.0017120793,0.5577592,0.36415523],"study_design_scores_gemma":[0.000081078164,0.000106475876,0.17208406,0.0015820772,0.000047657166,0.0028285068,0.01854233,0.00007897846,0.00015218127,0.0008472833,0.8036157,0.000033702458],"about_ca_topic_score_codex":0.22093578,"about_ca_topic_score_gemma":0.38347873,"teacher_disagreement_score":0.77906424,"about_ca_system_score_codex":0.0024482661,"about_ca_system_score_gemma":0.008517329,"threshold_uncertainty_score":0.7405601},"labels":[],"label_agreement":null},{"id":"W2802063352","doi":"10.1007/s40268-018-0232-1","title":"A Phase I Study of the Pharmacokinetics and Pharmacodynamics of Intranasal Doxylamine in Subjects with Chronic Intermittent Sleep Impairment","year":2018,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Obstructive Sleep Apnea Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"GlaxoSmithKline","keywords":"Nasal administration; Cmax; Pharmacokinetics; Medicine; Pharmacodynamics; Pharmacology; Bioavailability; Nasal spray; Dosing; Area under the curve; Oral administration; Anesthesia","score_opus":0.01161056248182597,"score_gpt":0.32922099346729156,"score_spread":0.3176104309854656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802063352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99445724,0.00074169197,0.0008082211,0.00013821317,0.000058492344,0.0029225415,0.0003582214,0.000042630247,0.00047281708],"genre_scores_gemma":[0.9895504,0.00092308247,0.0024376072,0.00046197214,0.00012636205,0.0040791417,0.0007239994,0.000021856393,0.0016755139],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995883,0.0001676126,0.000025966205,0.00008815716,0.00004794855,0.00008207251],"domain_scores_gemma":[0.99915564,0.0001431699,0.00020689146,0.00010061203,0.00009786067,0.00029572085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012054386,0.0011612396,0.0015674536,0.00027268654,0.00040307693,0.00055950263,0.0006844697,0.0008522877,0.002733425],"category_scores_gemma":[0.00094636035,0.0005896133,0.0009735043,0.00027228257,0.00072645955,0.00047103426,0.00027132634,0.0018719443,0.00051764114],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6726339,0.13229401,0.009236168,0.00096664875,0.0013346291,0.00021923453,0.00048138542,0.0012649954,0.0982519,0.00014745713,0.0015255352,0.081644155],"study_design_scores_gemma":[0.20133857,0.7778667,0.014127964,0.000018435398,0.0003510926,0.00010786196,0.00005090944,0.00062126917,0.0044033728,0.000051212617,0.0010444664,0.000018243361],"about_ca_topic_score_codex":0.0011070748,"about_ca_topic_score_gemma":0.0019510457,"teacher_disagreement_score":0.002733425,"about_ca_system_score_codex":0.0006511162,"about_ca_system_score_gemma":0.0015538061,"threshold_uncertainty_score":0.009144247},"labels":[],"label_agreement":null},{"id":"W2898934370","doi":"10.1007/s40268-018-0253-9","title":"Efficacy and Safety of Budesonide in the Treatment of Eosinophilic Esophagitis: Updated Systematic Review and Meta-Analysis of Randomized and Non-Randomized Studies","year":2018,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Randomized controlled trial; Medicine; Budesonide; Internal medicine; Meta-analysis; Eosinophilic esophagitis; Cochrane Library; Placebo; Confidence interval; Relative risk; Adverse effect; Gastroenterology; Asthma; Pathology; Disease","score_opus":0.06042388775615146,"score_gpt":0.3792141270448372,"score_spread":0.3187902392886857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898934370","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024564986,0.9958072,0.00042433784,0.00021184907,0.00016573888,0.00034354502,0.00040025814,0.000018871766,0.00017169923],"genre_scores_gemma":[0.08424626,0.90906143,0.002790264,0.0010860048,0.00030968315,0.0013340708,0.00091007043,0.000029609455,0.00023266906],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97981846,0.008211139,0.007363882,0.0014640386,0.0026757827,0.00046674444],"domain_scores_gemma":[0.97210556,0.017240636,0.0062032356,0.0008527054,0.0032630682,0.00033475467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025225066,0.003028569,0.024370383,0.0098096505,0.000649792,0.0037424609,0.0026717973,0.0027814473,0.0035473616],"category_scores_gemma":[0.052952483,0.0019340798,0.0419418,0.008389032,0.00084047037,0.002416306,0.0018090628,0.0022143798,0.00029162297],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015394187,0.000034740915,0.002490537,0.4947985,0.48544553,0.00011829344,0.00007916559,0.00035610946,0.00020250297,0.00012123251,0.00057932484,0.014234667],"study_design_scores_gemma":[0.0005907189,0.00017457154,0.0020880292,0.034507282,0.96082747,0.00008764332,0.000032746357,0.000109180124,0.00010484341,0.00012670322,0.0013292652,0.000021541118],"about_ca_topic_score_codex":0.0064822286,"about_ca_topic_score_gemma":0.012510571,"teacher_disagreement_score":0.025225066,"about_ca_system_score_codex":0.0035012017,"about_ca_system_score_gemma":0.0061488063,"threshold_uncertainty_score":0.13340443},"labels":[],"label_agreement":null},{"id":"W2900862674","doi":"10.1007/s40268-018-0255-7","title":"Post Hoc Analysis of the CONFIDENCE II, PROTECT I, SHAKE THE HABIT I and SHAKE THE HABIT II Observational Studies in Mild to Moderate Hypertensive Patients Treated with Perindopril and Atorvastatin Concomitantly","year":2018,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"Institut de Recherches Servier","keywords":"Shake; Perindopril; Medicine; Post-hoc analysis; Observational study; Internal medicine; Post hoc; Cardiology; Engineering; Blood pressure","score_opus":0.06154146838293655,"score_gpt":0.2998606053313985,"score_spread":0.23831913694846196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900862674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914204,0.0020282124,0.0029462217,0.00010269387,0.00021375642,0.0008504018,0.0017315848,0.000045220724,0.0006614957],"genre_scores_gemma":[0.9938069,0.00020352073,0.0027572196,0.00013199857,0.000094527844,0.00096112274,0.0012785667,0.000026523494,0.0007395123],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9707718,0.02046823,0.0020887188,0.002745132,0.0023625707,0.0015635585],"domain_scores_gemma":[0.9477759,0.036261734,0.0068681696,0.0050548133,0.0025126133,0.0015268065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025562797,0.0011778869,0.0030231131,0.001229246,0.00049548567,0.00093318935,0.0011373911,0.00087423023,0.0025629022],"category_scores_gemma":[0.027974637,0.00047646207,0.009175481,0.0010278921,0.0007595801,0.000595514,0.00094620755,0.0013889294,0.00011073825],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4216124,0.0012701392,0.41613308,0.001969388,0.13372312,0.0005471621,0.00081963826,0.0018082205,0.005169162,0.00047893592,0.002338882,0.014129938],"study_design_scores_gemma":[0.019307446,0.07842082,0.811554,0.00014883149,0.071170956,0.00040896144,0.00067649875,0.009663298,0.0030843765,0.00044102152,0.0050067045,0.00011701218],"about_ca_topic_score_codex":0.0042354427,"about_ca_topic_score_gemma":0.006358929,"teacher_disagreement_score":0.025562797,"about_ca_system_score_codex":0.0007881423,"about_ca_system_score_gemma":0.0018969859,"threshold_uncertainty_score":0.1351906},"labels":[],"label_agreement":null},{"id":"W2919757880","doi":"10.1007/s40268-019-0263-2","title":"Ulcerative Colitis: Shifting Sands","year":2019,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Pfizer","keywords":"Medicine; Ulcerative colitis; Disease; Inflammatory bowel disease; Quality of life (healthcare); Proctitis; Internal medicine; Colitis; Intensive care medicine; Gastroenterology","score_opus":0.021497418436796062,"score_gpt":0.31606787759129235,"score_spread":0.2945704591544963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919757880","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009375864,0.9945809,0.00009794151,0.0015027407,0.0012690171,0.0000039366073,0.0000189751,0.000012905953,0.0024198696],"genre_scores_gemma":[0.0008732241,0.9939084,0.00014667901,0.0016235709,0.0012518918,0.000005895507,0.00003748691,0.0000039659644,0.002148881],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9996679,0.00006579695,0.00005726119,0.00006033665,0.00011826847,0.000030462072],"domain_scores_gemma":[0.99961543,0.00016773836,0.000051726092,0.000015805565,0.00010192454,0.000047353944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005130253,0.0008516942,0.0013430741,0.0021943487,0.0004363115,0.0016411314,0.00071502523,0.0014705277,0.004838475],"category_scores_gemma":[0.0011323451,0.00023093788,0.0005508003,0.0016338774,0.0008519158,0.0022179382,0.0009245388,0.0025124636,0.0035052637],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008042892,0.000026494454,0.000192103,0.00846201,0.00006184869,0.00027027383,0.00008421389,0.0001784984,0.00040349973,0.0063640745,0.11538867,0.86848795],"study_design_scores_gemma":[0.0000107453225,0.00003033658,0.00047436522,0.00372196,0.000036059337,0.0016700635,0.00006303505,0.000026921845,0.000072149596,0.0024033345,0.99148023,0.000010949775],"about_ca_topic_score_codex":0.0014205491,"about_ca_topic_score_gemma":0.0023054664,"teacher_disagreement_score":0.004838475,"about_ca_system_score_codex":0.0008703724,"about_ca_system_score_gemma":0.001098412,"threshold_uncertainty_score":0.016186297},"labels":[],"label_agreement":null},{"id":"W3020645024","doi":"10.1007/s40268-020-00307-2","title":"Public Health Outcomes May Differ After Switching from Brand-Name to Generic Angiotensin II Receptor Blockers","year":2020,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut Universitaire de Cardiologie et de Pneumologie de Québec; Université Laval; Institut National de Santé Publique du Québec","funders":"Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval; Institut National de Santé Publique du Québec","keywords":"Angiotensin Receptor Blockers; Pharmacology; Brand names; Business; Chemistry; Medicine; Internal medicine; Renin–angiotensin system; Advertising","score_opus":0.10373590454889006,"score_gpt":0.28739270910938797,"score_spread":0.1836568045604979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020645024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956416,0.00042142373,0.00024343822,0.0003034721,0.000017043296,0.000023709144,0.0017049205,0.000009173394,0.0016350934],"genre_scores_gemma":[0.9987301,0.00011747865,0.00007386306,0.000075894925,0.000015287183,0.000011322075,0.0008620164,0.0000026931448,0.00011132821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976076,0.00060334476,0.00017831997,0.0004753374,0.00048991607,0.00064550363],"domain_scores_gemma":[0.9893868,0.0020160389,0.0061953394,0.0007183605,0.0010848357,0.0005986192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00320405,0.00024017229,0.00030439324,0.001371893,0.00040119656,0.0012209807,0.00046062344,0.00062249065,0.0015737009],"category_scores_gemma":[0.0109317945,0.00018704365,0.0010101402,0.0017562982,0.00048800223,0.0006887807,0.00053819024,0.000826638,0.00025141297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011497937,0.00002731278,0.9981269,0.000008523791,0.00008623893,0.00003962262,0.00006882744,0.000058839687,0.000042484717,0.00004154689,0.00009066465,0.0012941109],"study_design_scores_gemma":[0.000003315706,0.00003324963,0.9996228,0.000004167836,0.000032155425,0.000030998184,0.000054668544,0.00008248118,0.000023545635,0.0000442575,0.00006611312,0.0000021808064],"about_ca_topic_score_codex":0.030737277,"about_ca_topic_score_gemma":0.030257463,"teacher_disagreement_score":0.030737277,"about_ca_system_score_codex":0.0013895114,"about_ca_system_score_gemma":0.0010763285,"threshold_uncertainty_score":0.061116755},"labels":[],"label_agreement":null},{"id":"W3085493311","doi":"10.1007/s40268-020-00322-3","title":"Nimodipine Pharmacokinetic Variability in Various Patient Populations","year":2020,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Intracranial Aneurysms: Treatment and Complications","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Nimodipine; Medicine; Pharmacokinetics; Subarachnoid hemorrhage; Dosing; Anesthesia; MEDLINE; Clinical significance; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.04794077184678272,"score_gpt":0.3501292232052786,"score_spread":0.3021884513584959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085493311","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023708148,0.99644744,0.00017021073,0.00025515663,0.000037632555,0.000042664426,0.00032153135,0.0000038026897,0.0003507198],"genre_scores_gemma":[0.03317088,0.9647352,0.00072067854,0.0006437326,0.00012193113,0.00014735642,0.0003700543,0.000004991163,0.00008515827],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954407,0.0012847317,0.001973232,0.00048086004,0.0007411626,0.00007928824],"domain_scores_gemma":[0.9825957,0.0137030175,0.0028816413,0.00018568042,0.0005866168,0.000047409296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038916587,0.00052420597,0.0028201162,0.00478822,0.00027701518,0.0013491297,0.0007548458,0.0009194967,0.001369435],"category_scores_gemma":[0.019007852,0.0003113312,0.0026310156,0.0059212684,0.00041709188,0.0009911564,0.00057344825,0.0005758486,0.00012874033],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055870105,0.000053403757,0.011595096,0.6320673,0.0079235565,0.0009174252,0.00074479333,0.0004076294,0.0010170377,0.0012273192,0.0039916267,0.33949602],"study_design_scores_gemma":[0.000495667,0.0009960182,0.093167774,0.6413552,0.07724422,0.012247693,0.002195392,0.0006252337,0.002272815,0.003772969,0.16538408,0.00024292537],"about_ca_topic_score_codex":0.0029509598,"about_ca_topic_score_gemma":0.004773335,"teacher_disagreement_score":0.00478822,"about_ca_system_score_codex":0.0011361992,"about_ca_system_score_gemma":0.0030175406,"threshold_uncertainty_score":0.020581305},"labels":[],"label_agreement":null},{"id":"W3092259600","doi":"10.1007/s40268-020-00323-2","title":"Comparisons of Four Protein-Binding Models Characterizing the Pharmacokinetics of Unbound Phenytoin in Adult Patients Using Non-Linear Mixed-Effects Modeling","year":2020,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of Alberta","funders":"National Research Foundation of Korea","keywords":"Pharmacokinetics; Phenytoin; Pharmacology; Medicine; Chemistry; Epilepsy","score_opus":0.07519172777881467,"score_gpt":0.3256941495750178,"score_spread":0.25050242179620313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092259600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56036097,0.0014906191,0.4327507,0.00088873354,0.00009035364,0.0009978092,0.0015138533,0.0007344912,0.0011724784],"genre_scores_gemma":[0.9110831,0.00044179716,0.084260285,0.00021671105,0.000028322149,0.0013994981,0.0013478507,0.00011401675,0.0011084343],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99251866,0.006118042,0.00022914942,0.00066732534,0.00024541863,0.00022134013],"domain_scores_gemma":[0.9717541,0.025943512,0.00090321276,0.00036574344,0.0007775013,0.00025591222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016843975,0.002059893,0.0019929658,0.0013423332,0.0004846894,0.0013892951,0.0025761104,0.0013979259,0.0018792712],"category_scores_gemma":[0.026238509,0.0008250268,0.005617673,0.00060898997,0.0005167129,0.0007891802,0.001000644,0.0019723508,0.0003283062],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004643242,0.0008154375,0.037669767,0.00048428238,0.0040929206,0.00029018073,0.0005363647,0.90548944,0.0017612283,0.0060212784,0.0010753258,0.03712053],"study_design_scores_gemma":[0.0001728463,0.00057515875,0.002909694,0.00002971551,0.00053262245,0.000033732602,0.000046426943,0.99318564,0.0003787176,0.0017865375,0.00031935485,0.000029595427],"about_ca_topic_score_codex":0.015758572,"about_ca_topic_score_gemma":0.010809262,"teacher_disagreement_score":0.016843975,"about_ca_system_score_codex":0.001797456,"about_ca_system_score_gemma":0.0026964315,"threshold_uncertainty_score":0.08908051},"labels":[],"label_agreement":null},{"id":"W3156032412","doi":"10.1007/s40268-021-00345-4","title":"Ammonia Removal by Metabolic Scavengers for the Prevention and Treatment of Hepatic Encephalopathy in Cirrhosis","year":2021,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Hyperammonemia; Urea cycle; Hepatic encephalopathy; Lactulose; Cirrhosis; Internal medicine; Ornithine; Chemistry; Phenylbutyrate; Medicine; Endocrinology; Biochemistry; Pharmacology; Arginine; Amino acid","score_opus":0.03239207941204482,"score_gpt":0.3379310956392957,"score_spread":0.3055390162272509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156032412","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011844979,0.99960905,0.000019020843,0.000055047505,0.000033240736,0.0000048611064,0.000014374825,0.0000023537125,0.00014360159],"genre_scores_gemma":[0.0011473857,0.99855465,0.00006891468,0.00007470231,0.000031194355,0.000007681733,0.000024431733,6.999125e-7,0.000090348934],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997451,0.00007346111,0.00006389988,0.000031206,0.000065651024,0.000020651827],"domain_scores_gemma":[0.99938905,0.00037020582,0.00012998722,0.000011386086,0.000079138656,0.000020260122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000736776,0.0006491418,0.002024839,0.0024170692,0.00017611044,0.00070601294,0.00081304193,0.001037431,0.0047053564],"category_scores_gemma":[0.0015871314,0.00023552241,0.0019217217,0.0020865689,0.00023468565,0.0006616546,0.0004303977,0.00086578715,0.00064758526],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003842651,0.00009443812,0.00024965362,0.24463293,0.0017230551,0.00013407393,0.000056617948,0.00026043213,0.0008140336,0.0009337567,0.012168899,0.738548],"study_design_scores_gemma":[0.00081242033,0.0009104387,0.008113813,0.2214565,0.018268092,0.0030729743,0.00023722324,0.00045495664,0.0018599838,0.00255167,0.7421724,0.00008950505],"about_ca_topic_score_codex":0.0014839973,"about_ca_topic_score_gemma":0.0031659638,"teacher_disagreement_score":0.0047053564,"about_ca_system_score_codex":0.0005058829,"about_ca_system_score_gemma":0.0009383775,"threshold_uncertainty_score":0.01574105},"labels":[],"label_agreement":null},{"id":"W3173963108","doi":"10.1007/s40268-021-00351-6","title":"Potential for the Repurposing of Adamantane Antivirals for COVID-19","year":2021,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Amantadine; Memantine; Coronavirus; Rimantadine; Virology; Drug repositioning; Pharmacology; Viral replication; Biology; Virus; Receptor; Medicine; NMDA receptor; Influenza A virus; Drug; Biochemistry; Coronavirus disease 2019 (COVID-19); Disease","score_opus":0.11603596838926164,"score_gpt":0.4612790641218202,"score_spread":0.3452430957325585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173963108","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47973236,0.41065237,0.035819873,0.0052034534,0.0020196992,0.0009338455,0.0021142298,0.00058928644,0.06293494],"genre_scores_gemma":[0.8133047,0.12564375,0.019159181,0.0019603183,0.00040960062,0.0002496723,0.0020774757,0.00007833073,0.03711694],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998635,0.000035984955,0.000009002211,0.000022158356,0.000034903565,0.00003438732],"domain_scores_gemma":[0.99990666,0.00001307513,0.000020370126,0.000009989414,0.000026763057,0.000023027937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035583036,0.00045846257,0.00035711937,0.000438109,0.00022165528,0.0005879287,0.00039924393,0.0005820839,0.007790541],"category_scores_gemma":[0.00023551792,0.00016932742,0.00076617923,0.00019485419,0.00019375815,0.0005731734,0.0003685099,0.00084385806,0.001782725],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009145845,0.0007533361,0.0010122132,0.0017710646,0.00012834517,0.0013618779,0.0001320178,0.0015726822,0.8104765,0.0060154865,0.006166929,0.16969503],"study_design_scores_gemma":[0.0004732597,0.008698209,0.0038810938,0.00033754064,0.00021173609,0.003914364,0.00015496284,0.003660281,0.5479613,0.0037054517,0.42693755,0.000064231135],"about_ca_topic_score_codex":0.00037925874,"about_ca_topic_score_gemma":0.00071644,"teacher_disagreement_score":0.007790541,"about_ca_system_score_codex":0.00027092,"about_ca_system_score_gemma":0.00029200214,"threshold_uncertainty_score":0.026061952},"labels":[],"label_agreement":null},{"id":"W3200529384","doi":"10.1007/s40268-021-00361-4","title":"The Safety of Agalsidase Alfa Enzyme Replacement Therapy in Canadian Patients with Fabry Disease Following Implementation of a Bioreactor Process","year":2021,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of Toronto; University Health Network; University of British Columbia; Alberta Children's Hospital; Queen Elizabeth II Health Sciences Centre; Université de Montréal; Hôpital du Sacré-Cœur de Montréal; University of Calgary","funders":"Killam Trusts","keywords":"Enzyme replacement therapy; Fabry disease; Medicine; Adverse effect; Internal medicine; Disease","score_opus":0.010119529080312509,"score_gpt":0.31440482041907347,"score_spread":0.304285291338761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200529384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978278,0.0008119692,0.00016358559,0.00008649729,0.000005721422,0.000096355754,0.00012641963,0.0000061293804,0.000875505],"genre_scores_gemma":[0.99886,0.0003212064,0.0003017055,0.00010196987,0.00000659008,0.000028887243,0.0001758777,0.0000011999539,0.00020258523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99941015,0.00011338523,0.000027457994,0.000065402855,0.0002800232,0.000103654245],"domain_scores_gemma":[0.9988945,0.00016945756,0.00043399574,0.00003831946,0.00027323244,0.00019036498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001141893,0.00022620261,0.00037054057,0.0001564456,0.00077932555,0.0004389899,0.00031752908,0.00026695136,0.0008230963],"category_scores_gemma":[0.0017793254,0.00009094894,0.0002849053,0.00038482697,0.00047352765,0.00015092475,0.00019630596,0.00049400487,0.000087968256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06756115,0.0033573245,0.66522795,0.0009421706,0.0006245662,0.0018790796,0.0026746946,0.0018516028,0.05557214,0.0006787307,0.0035254692,0.1961052],"study_design_scores_gemma":[0.0034626857,0.05500485,0.91489446,0.00013947306,0.0005405353,0.0024862802,0.0009956,0.0024353026,0.0105301235,0.000105823354,0.009332949,0.00007190051],"about_ca_topic_score_codex":0.21900976,"about_ca_topic_score_gemma":0.29108003,"teacher_disagreement_score":0.78099024,"about_ca_system_score_codex":0.0071259956,"about_ca_system_score_gemma":0.008147763,"threshold_uncertainty_score":0.43546999},"labels":[],"label_agreement":null},{"id":"W4211044495","doi":"10.1007/bf03259788","title":"Telaprevir","year":2010,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Telaprevir; Virology","score_opus":0.017478495273752663,"score_gpt":0.351250165184447,"score_spread":0.33377166991069435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211044495","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12486859,0.24388038,0.010998503,0.01279777,0.0035793923,0.0016802164,0.011069675,0.003656278,0.5874692],"genre_scores_gemma":[0.57693565,0.07126104,0.0072940737,0.016481094,0.0011343961,0.0010541442,0.013626633,0.00021286879,0.31200016],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998573,0.00003277772,0.000012733062,0.000025298772,0.0000433301,0.00002840698],"domain_scores_gemma":[0.9999043,0.000016145776,0.00001449674,0.000009203983,0.000018756169,0.00003712259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017800445,0.00030282498,0.00038617404,0.00022120518,0.00018900675,0.00046730507,0.00036612156,0.000468485,0.03772024],"category_scores_gemma":[0.00035528094,0.00007781395,0.00029517597,0.0001724962,0.000119839235,0.0003402908,0.00025982302,0.0012418802,0.018753989],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062193307,0.00087711646,0.0008475247,0.0014321278,0.00010890004,0.00076620065,0.000059646696,0.0003089653,0.026247941,0.0027205471,0.06884968,0.891562],"study_design_scores_gemma":[0.0048890105,0.005082591,0.0048509478,0.00039329435,0.00014009576,0.0072745867,0.000060994873,0.00045497288,0.022825586,0.0017097228,0.95228195,0.00003617806],"about_ca_topic_score_codex":0.00027617082,"about_ca_topic_score_gemma":0.0005141177,"teacher_disagreement_score":0.03772024,"about_ca_system_score_codex":0.00028199857,"about_ca_system_score_gemma":0.00025954473,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4211130856","doi":"10.2165/11586020-000000000-00000","title":"Telaprevir","year":2010,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Hepatitis C virus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Telaprevir; Ribavirin; Medicine; Pegylated interferon; Pharmacology; Protease inhibitor (pharmacology); Hepatitis C virus; Clinical trial; Virology; Combination therapy; Internal medicine; Virus; Viral load","score_opus":0.0885571778742468,"score_gpt":0.45540974985999433,"score_spread":0.3668525719857475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211130856","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013520935,0.9730156,0.00051386876,0.00062177476,0.00047467748,0.00007017008,0.00027714242,0.000075614786,0.023599058],"genre_scores_gemma":[0.013774714,0.9597685,0.0009835885,0.001431219,0.00036133057,0.00008927998,0.0007073791,0.000010228081,0.022873774],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998939,0.000019843457,0.000011862322,0.000022192105,0.00003923834,0.000012922955],"domain_scores_gemma":[0.99994946,0.0000146427365,0.00001137164,0.0000022672139,0.000012339431,0.000009962877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016438033,0.00049247633,0.0006879892,0.0008025297,0.00017217496,0.0005341394,0.00051456084,0.00054957217,0.014228697],"category_scores_gemma":[0.00025317012,0.00012905363,0.00037940376,0.00058380683,0.00012452221,0.00043442877,0.00030491693,0.00097586174,0.009328521],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021904259,0.00009567026,0.00008930325,0.0050345957,0.000056909277,0.00023046411,0.000023525055,0.00010450321,0.0030324664,0.0010533736,0.032439135,0.95762116],"study_design_scores_gemma":[0.00020597437,0.0002653702,0.0008435354,0.0012864122,0.00009026503,0.0030001926,0.000027898739,0.00006863393,0.0020161374,0.00062726537,0.99155575,0.000012564446],"about_ca_topic_score_codex":0.00056297117,"about_ca_topic_score_gemma":0.0012007419,"teacher_disagreement_score":0.014228697,"about_ca_system_score_codex":0.00026234036,"about_ca_system_score_gemma":0.00033220943,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4232278611","doi":"10.1007/bf03259727","title":"Impact of Intravenous Naltrexone on Intravenous Morphine-Induced High, Drug Liking, and Euphoric Effects in Experienced, Nondependent Male Opioid Users","year":2011,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"Shionogi; Astellas Pharma; Purdue University; Eisai; Bayer HealthCare; Boston Scientific Corporation; Purdue Pharma; Gilead Sciences; GlaxoSmithKline; Nevro; Teva Pharmaceutical Industries; AstraZeneca; Pfizer","keywords":"Euphoriant; Naltrexone; Morphine; Medicine; Heroin; Anesthesia; Opioid; Narcotic antagonist; Visual analogue scale; Pharmacology; Drug; Internal medicine; Psychiatry","score_opus":0.0124207090589173,"score_gpt":0.26841392998418573,"score_spread":0.25599322092526844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232278611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99973136,0.00005650135,0.000021779118,0.000006296005,0.0000034013506,0.00003922874,0.000024200002,0.0000023998157,0.000114789735],"genre_scores_gemma":[0.99945194,0.000080232334,0.00014982071,0.000031559288,0.000011813725,0.000045021505,0.000051870506,0.0000013569306,0.00017634517],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995453,0.00023308971,0.000045468085,0.00004842204,0.00007889125,0.000048742095],"domain_scores_gemma":[0.9991003,0.00035644998,0.00022829446,0.000051816816,0.000040145085,0.00022300261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056755176,0.00028946457,0.0004085721,0.00012062181,0.00014215709,0.00027344856,0.00020688,0.0002883402,0.0022178865],"category_scores_gemma":[0.0018664818,0.00020026574,0.00039166765,0.00008875745,0.00030765947,0.00027004036,0.00019584324,0.00048596025,0.00015707024],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.504052,0.0952432,0.08338332,0.0011022465,0.0009946459,0.00044127525,0.0005294505,0.0013020235,0.19148971,0.00010447964,0.00033538387,0.121022224],"study_design_scores_gemma":[0.016999934,0.71601605,0.24964389,0.000030147017,0.00029079427,0.00035801993,0.00017277728,0.0012752386,0.0147488145,0.000032015007,0.00040436635,0.000027939648],"about_ca_topic_score_codex":0.00036153852,"about_ca_topic_score_gemma":0.0007127988,"teacher_disagreement_score":0.0022178865,"about_ca_system_score_codex":0.00019929255,"about_ca_system_score_gemma":0.00019212159,"threshold_uncertainty_score":0.007419586},"labels":[],"label_agreement":null},{"id":"W4249646940","doi":"10.1007/bf03262369","title":"Food Effects on the Pharmacokinetics of Doxylamine Hydrogen Succinate 25 mg Film-Coated Tablets","year":2012,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Poisoning and overdose treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Pharmacokinetics; Pharmacology; Bioavailability; Antihistamine; Crossover study; Medicine; Chemistry; Placebo","score_opus":0.013966316615822266,"score_gpt":0.2747078549690658,"score_spread":0.26074153835324354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249646940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980982,0.00082336535,0.00040474237,0.000028496617,0.000026059595,0.000112221634,0.00013553785,0.000030163397,0.00034129625],"genre_scores_gemma":[0.99683845,0.00073386077,0.0010012209,0.00007733368,0.000034164448,0.00009647306,0.00028431695,0.000013929618,0.0009202078],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99964905,0.0001536286,0.000026176018,0.000065858985,0.00006421677,0.000040969986],"domain_scores_gemma":[0.9995147,0.00016653912,0.00015442388,0.000052357,0.00004038704,0.00007162847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048560483,0.00035484307,0.0006207299,0.00020529484,0.00014829816,0.0003179374,0.0002126579,0.00035852843,0.0011118307],"category_scores_gemma":[0.0010882568,0.00033171,0.00039622225,0.00018486581,0.00034229815,0.0002988438,0.000121110475,0.0005586357,0.00023518693],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.220306,0.0058158324,0.004864735,0.00038292873,0.00036156934,0.00031485956,0.00025655568,0.00068515696,0.69948655,0.00012136793,0.0005764405,0.0668281],"study_design_scores_gemma":[0.017456498,0.5195122,0.14814223,0.000059527825,0.0008879018,0.00084719015,0.0002488702,0.0076790773,0.29862213,0.00013240294,0.0063110883,0.00010090328],"about_ca_topic_score_codex":0.00055058644,"about_ca_topic_score_gemma":0.00074323994,"teacher_disagreement_score":0.0011118307,"about_ca_system_score_codex":0.00022921061,"about_ca_system_score_gemma":0.00036886873,"threshold_uncertainty_score":0.003719449},"labels":[],"label_agreement":null},{"id":"W4251062930","doi":"10.1007/bf03259789","title":"Boceprevir","year":2010,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Boceprevir; Medicine; Pharmacology; Virology; Ribavirin; Hepatitis C virus","score_opus":0.010330449689600741,"score_gpt":0.29738400725835723,"score_spread":0.2870535575687565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251062930","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1297982,0.4738548,0.010082583,0.012882354,0.005531313,0.0018618805,0.015567056,0.0034131925,0.34700862],"genre_scores_gemma":[0.65374315,0.12926242,0.012314201,0.014367453,0.0011412767,0.0010539735,0.017404085,0.00023745146,0.17047599],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999782,0.000049317514,0.00001899337,0.000031757536,0.000069765476,0.000048207614],"domain_scores_gemma":[0.99989676,0.000015746422,0.000017634786,0.000008869493,0.000027370395,0.00003352893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032151563,0.00035297897,0.0005404769,0.00034553374,0.00022222685,0.00036457373,0.0003247936,0.0004472498,0.022157548],"category_scores_gemma":[0.00051181717,0.00009228023,0.00037336117,0.0002765908,0.00010962581,0.0002592922,0.000203131,0.001147599,0.010433624],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0097176405,0.0005881969,0.0010853851,0.0026261325,0.00022116414,0.00082456734,0.000056148943,0.00036787678,0.023576235,0.0031405971,0.09299219,0.86480385],"study_design_scores_gemma":[0.0037888922,0.004457391,0.0073110294,0.00049699494,0.00019545393,0.004451524,0.000031019794,0.00030021163,0.010970384,0.0010310219,0.9669253,0.000040844607],"about_ca_topic_score_codex":0.0009413747,"about_ca_topic_score_gemma":0.0018556126,"teacher_disagreement_score":0.022157548,"about_ca_system_score_codex":0.00045877576,"about_ca_system_score_gemma":0.0002539682,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4283169331","doi":"10.1007/s40268-022-00391-6","title":"Analysis of the US Safety Data for Edaravone (Radicava®) From the Third Year After Launch","year":2022,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Adverse effect; Edaravone; Amyotrophic lateral sclerosis; Postmarketing surveillance; Clinical trial; Disease; Intensive care medicine; Internal medicine","score_opus":0.03374131150750272,"score_gpt":0.31307372465809863,"score_spread":0.2793324131505959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283169331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7267733,0.020025482,0.004953446,0.002148149,0.00027252798,0.0011058953,0.22469491,0.00048812325,0.019538091],"genre_scores_gemma":[0.8469249,0.0062163104,0.0019932499,0.0016574906,0.00020102582,0.0008350242,0.13888921,0.00010672491,0.0031761073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99477226,0.00091921876,0.0011025576,0.0005335509,0.0023495797,0.0003227909],"domain_scores_gemma":[0.97012186,0.00578788,0.015050895,0.0011776041,0.0073021227,0.0005595801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006419301,0.000332674,0.00047888167,0.002458987,0.00030857333,0.00095850276,0.0004136886,0.0003820826,0.004086641],"category_scores_gemma":[0.013262089,0.00021449859,0.0016379497,0.0037273632,0.00025750435,0.0005249425,0.0005373133,0.00089694397,0.001068287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009683916,0.00036714715,0.78667706,0.0028160943,0.0024791192,0.00061051006,0.0003524169,0.0022436557,0.0030909006,0.0008523866,0.04600245,0.1448243],"study_design_scores_gemma":[0.00042976753,0.001900561,0.91136765,0.0008664735,0.0011872838,0.0014078988,0.00025082057,0.0018459611,0.0042629843,0.00041295707,0.07600419,0.00006348098],"about_ca_topic_score_codex":0.005959238,"about_ca_topic_score_gemma":0.0060804836,"teacher_disagreement_score":0.006419301,"about_ca_system_score_codex":0.0015672962,"about_ca_system_score_gemma":0.0033633853,"threshold_uncertainty_score":0.0339489},"labels":[],"label_agreement":null},{"id":"W4289299681","doi":"10.1007/s40268-018-0252-x","title":"Acknowledgement to Referees","year":2018,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; Consejo Nacional de Investigaciones Científicas y Técnicas; Semmelweis Egyetem; Feinberg School of Medicine; Nirma University; Monash University; Universität Heidelberg; Universität Basel; University of British Columbia; Cleveland Clinic; Northwestern University","keywords":"Acknowledgement; Medicine; Psychology; Computer science","score_opus":0.011999333055938859,"score_gpt":0.30187290754508883,"score_spread":0.28987357448914997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289299681","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006087069,0.008614952,0.005436129,0.33772644,0.617235,0.0004937015,0.006387267,0.0020425727,0.021455158],"genre_scores_gemma":[0.02669945,0.011054618,0.015470278,0.26510793,0.36753568,0.0023489997,0.008303304,0.0051862006,0.29829347],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97345936,0.008778341,0.0035889107,0.00234295,0.010438057,0.0013923862],"domain_scores_gemma":[0.5652554,0.043624375,0.010443978,0.012651385,0.35472402,0.013300822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016852837,0.0020771667,0.0029311713,0.00865323,0.0044998834,0.00819548,0.003213871,0.0048820083,0.12658185],"category_scores_gemma":[0.26286414,0.00070239796,0.0021583224,0.0058845016,0.0018331471,0.0053682304,0.0050379154,0.010323129,0.08270565],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000217584,0.000007040044,0.00007759074,0.00012540935,0.000007672683,0.000116959134,0.00023974963,0.000025880667,0.00014362422,0.0010267489,0.9931545,0.0050530685],"study_design_scores_gemma":[0.000016976906,0.000008042529,0.00042187414,0.00031698457,0.000022893779,0.00029379982,0.000586568,0.00011340017,0.0001578037,0.0019852258,0.99602675,0.00004967219],"about_ca_topic_score_codex":0.017054947,"about_ca_topic_score_gemma":0.017075103,"teacher_disagreement_score":0.12658185,"about_ca_system_score_codex":0.0083462065,"about_ca_system_score_gemma":0.011610805,"threshold_uncertainty_score":0.42345846},"labels":[],"label_agreement":null},{"id":"W4312064980","doi":"10.1007/s40268-022-00410-6","title":"A Randomised Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of Palovarotene Ophthalmic Solution","year":2022,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Altasciences (Canada)","funders":"Ipsen","keywords":"Tolerability; Medicine; Pharmacokinetics; Adverse effect; Placebo; Internal medicine; Anesthesia","score_opus":0.03184393169426662,"score_gpt":0.3427165005340247,"score_spread":0.31087256883975806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312064980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93591094,0.004524433,0.0036224145,0.0008154596,0.001320275,0.047339365,0.002973693,0.0002130575,0.0032803873],"genre_scores_gemma":[0.93390507,0.0034656264,0.0076260106,0.0019647437,0.0007967277,0.041378364,0.0018890449,0.00005660763,0.0089179175],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99879694,0.0006075015,0.00008464738,0.00023698437,0.00012846726,0.00014547646],"domain_scores_gemma":[0.9980313,0.00048142183,0.0005733728,0.00021410956,0.00019251464,0.0005073029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002961912,0.0014068714,0.0028566576,0.00042942722,0.00044512528,0.0010074851,0.0010043235,0.0016095296,0.0126006715],"category_scores_gemma":[0.0029946151,0.00091025507,0.0011324158,0.00048822438,0.0012842915,0.0011038918,0.0004361319,0.0019892855,0.0016008646],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9570636,0.018315665,0.0006119755,0.00073663343,0.0004550267,0.00006397129,0.0000666205,0.00022943392,0.009407289,0.00017168163,0.0008341134,0.01204408],"study_design_scores_gemma":[0.79906106,0.19767256,0.0008999429,0.000033407734,0.00018315087,0.00004314616,0.000020422693,0.00019320178,0.00048730226,0.00013343852,0.0012610046,0.000011273568],"about_ca_topic_score_codex":0.00044628556,"about_ca_topic_score_gemma":0.0011262031,"teacher_disagreement_score":0.0126006715,"about_ca_system_score_codex":0.00073537277,"about_ca_system_score_gemma":0.0023802253,"threshold_uncertainty_score":0.042153418},"labels":[],"label_agreement":null},{"id":"W4319332896","doi":"10.1007/s40268-023-00413-x","title":"Risk of Adverse Events Associated with Domperidone and Metoclopramide in Gastroparesis: Systematic Review and Meta-analysis","year":2023,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"Takeda Pharmaceuticals U.S.A.","keywords":"Domperidone; Medicine; Gastroparesis; Metoclopramide; Meta-analysis; Internal medicine; Adverse effect; Odds ratio; Placebo; Extrapyramidal symptoms; Confidence interval; Antipsychotic; Gastric emptying; Schizophrenia (object-oriented programming); Dopamine; Psychiatry; Pathology","score_opus":0.058121926999395716,"score_gpt":0.3338852237016718,"score_spread":0.27576329670227606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319332896","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040490786,0.99431664,0.0005092558,0.00015633219,0.00011401405,0.00022094845,0.00043142147,0.000020422478,0.00018193782],"genre_scores_gemma":[0.17561828,0.81842697,0.0025356147,0.00081958395,0.00030219005,0.0011740435,0.00080172496,0.00003294134,0.00028867807],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98845077,0.005473576,0.0034891868,0.0010587837,0.0012442538,0.00028348537],"domain_scores_gemma":[0.97472376,0.018422738,0.004426349,0.0005879647,0.0015650428,0.00027411617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014472683,0.0028886045,0.017517975,0.0076303463,0.0005406906,0.002780974,0.0020840317,0.0022224763,0.0030432367],"category_scores_gemma":[0.034071278,0.0016677076,0.046341944,0.007947241,0.0006811331,0.0014862219,0.0016069211,0.001984077,0.00026904605],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013842841,0.000021420072,0.0039486163,0.32831836,0.65764076,0.00011194549,0.00005727587,0.0004537952,0.0001375003,0.00009113377,0.00036758967,0.007467319],"study_design_scores_gemma":[0.00034487798,0.00013876622,0.00283354,0.017388329,0.9779128,0.00010012377,0.000028077526,0.00016257133,0.000073511335,0.000115142444,0.00088597124,0.000016297718],"about_ca_topic_score_codex":0.0052521355,"about_ca_topic_score_gemma":0.010564939,"teacher_disagreement_score":0.017517975,"about_ca_system_score_codex":0.0023067927,"about_ca_system_score_gemma":0.0030427002,"threshold_uncertainty_score":0.076539755},"labels":[],"label_agreement":null},{"id":"W4386046570","doi":"10.1007/s40268-023-00428-4","title":"Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature","year":2023,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Oral and gingival health research","field":"Health Professions","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Tacrolimus; Everolimus; Sirolimus; Medicine; Calcineurin; Dosing; Therapeutic drug monitoring; Adverse effect; Pharmacology; Internal medicine; Ciclosporin; Transplantation; Drug","score_opus":0.21536481290553686,"score_gpt":0.5519977062624285,"score_spread":0.3366328933568916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386046570","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005796571,0.9988237,0.000044371878,0.00013393693,0.000087778186,0.000025168185,0.00009768253,0.000004086125,0.00020366594],"genre_scores_gemma":[0.0031257374,0.99614465,0.00013178935,0.00026508656,0.00012576353,0.000036696394,0.00009769126,0.0000016550547,0.000070914364],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99780065,0.00029517055,0.0012390264,0.00022677337,0.00036249548,0.00007577485],"domain_scores_gemma":[0.98894215,0.0074111396,0.0024316465,0.00012782868,0.00093062734,0.00015655298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002165455,0.0012611942,0.0036616223,0.013532976,0.00059466413,0.0015582584,0.0014107702,0.0013129164,0.0029948484],"category_scores_gemma":[0.0077328812,0.000642744,0.0033251652,0.01344393,0.00058977684,0.0018930654,0.000967733,0.00070932833,0.00040517884],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024644658,0.00004313398,0.0016535814,0.81746745,0.0022125624,0.0012119644,0.00038854365,0.0001547204,0.00060061045,0.00035721372,0.0072194715,0.16844423],"study_design_scores_gemma":[0.00016984325,0.00043836853,0.015744008,0.7873402,0.032433797,0.012357874,0.0008652857,0.00015278219,0.0006770761,0.0010260964,0.14868517,0.000109431705],"about_ca_topic_score_codex":0.0032234676,"about_ca_topic_score_gemma":0.0059540286,"teacher_disagreement_score":0.013532976,"about_ca_system_score_codex":0.0015199939,"about_ca_system_score_gemma":0.0039392705,"threshold_uncertainty_score":0.011452138},"labels":[],"label_agreement":null},{"id":"W4396608809","doi":"10.1007/s40268-024-00459-5","title":"Retrospective Assessment of Translational Pharmacokinetic–Pharmacodynamic Modeling Performance: A Case Study with Apitolisib, a Dual PI3K/mTOR Inhibitor","year":2024,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway; Pharmacodynamics; Pharmacokinetics; Dual (grammatical number); Pharmacology; Medicine; Chemistry; Biochemistry; Signal transduction; Philosophy","score_opus":0.011534756925297913,"score_gpt":0.3250791939346348,"score_spread":0.3135444370093369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396608809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97633535,0.00029197673,0.020466318,0.00019883795,0.000017122988,0.00012919349,0.00056947384,0.0002586859,0.0017329811],"genre_scores_gemma":[0.9928236,0.00016271583,0.006085857,0.000027990547,0.0000068831523,0.000043307442,0.00034363242,0.000047788344,0.000458293],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9993106,0.0002557554,0.000046039593,0.00016434635,0.00017743776,0.000045867273],"domain_scores_gemma":[0.996396,0.0020979596,0.00039191174,0.00048405444,0.0005215406,0.00010852629],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0026826027,0.0006326875,0.0005366837,0.0005607172,0.0003531264,0.0011071117,0.000640882,0.0009374138,0.0010868728],"category_scores_gemma":[0.0052999966,0.00025806372,0.0007156882,0.00043258283,0.00037367165,0.000534057,0.00046560945,0.00081966334,0.0003551781],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037049453,0.002648381,0.2267114,0.00039746345,0.0005830974,0.007704314,0.0010016961,0.60556525,0.049185183,0.0023834757,0.0045264857,0.0955884],"study_design_scores_gemma":[0.000100812096,0.002782564,0.04027655,0.000026900498,0.00020010084,0.0031047412,0.00038803436,0.9113281,0.03663789,0.0008219711,0.004236236,0.00009608024],"about_ca_topic_score_codex":0.005313326,"about_ca_topic_score_gemma":0.0030974655,"teacher_disagreement_score":0.9973174,"about_ca_system_score_codex":0.0007408483,"about_ca_system_score_gemma":0.0006329951,"threshold_uncertainty_score":0.014187098},"labels":[],"label_agreement":null},{"id":"W4399384704","doi":"10.1007/s40268-024-00462-w","title":"Safety and Efficacy of Lemborexant in Insomnia Patients: Results of a Postmarketing Observational Study of Dayvigo® Tablets","year":2024,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Sleep and related disorders","field":"Psychology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada; Eisai","keywords":"Somnolence; Postmarketing surveillance; Insomnia; Sleep paralysis; Medicine; Observational study; Suicidal ideation; Adverse effect; Sleep disorder; Psychiatry; Internal medicine; Poison control; Emergency medicine; Injury prevention; Excessive daytime sleepiness","score_opus":0.02254376746278476,"score_gpt":0.3118689907720825,"score_spread":0.2893252233092978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399384704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99939394,0.00021969694,0.000055749224,0.000012761131,0.0000035970502,0.00005708108,0.00011399772,0.0000031469924,0.00013993171],"genre_scores_gemma":[0.9992071,0.00013704925,0.00010194831,0.00005334727,0.000022059687,0.000046714522,0.00027453608,0.0000020857874,0.00015526326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993204,0.0001945108,0.00009697158,0.000105855295,0.00023532889,0.0000469816],"domain_scores_gemma":[0.99705744,0.00046939388,0.0016992394,0.00016042388,0.00034485615,0.00026877964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012743257,0.000321626,0.0005944445,0.0004169273,0.00044779686,0.00038522447,0.00020032973,0.00041800836,0.0012427558],"category_scores_gemma":[0.0031348222,0.00021859027,0.0007687309,0.00032311195,0.00021447775,0.0003922285,0.0002620114,0.000584867,0.00022660909],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012061939,0.0035934427,0.96013045,0.0003103343,0.00046179435,0.0005657435,0.0007420709,0.00009042171,0.006725197,0.000019852485,0.0002385489,0.015060193],"study_design_scores_gemma":[0.00058934256,0.01489477,0.9817523,0.00001629099,0.00025619657,0.00061467214,0.00019000965,0.0003176896,0.00094236014,0.000011077971,0.00039698897,0.000018232222],"about_ca_topic_score_codex":0.00084720243,"about_ca_topic_score_gemma":0.00089980994,"teacher_disagreement_score":0.0012743257,"about_ca_system_score_codex":0.00029436266,"about_ca_system_score_gemma":0.0003055985,"threshold_uncertainty_score":0.006739378},"labels":[],"label_agreement":null},{"id":"W4402785536","doi":"10.1007/s40268-024-00491-5","title":"Trametinib Sensitivity is Defined by a Myeloid Differentiation Profile in Acute Myeloid Leukemia","year":2024,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Institute of General Medical Sciences; National Cancer Institute; University of Pennsylvania; U.S. Department of Veterans Affairs","keywords":"Myeloid leukemia; Myeloid; Sensitivity (control systems); Trametinib; Myeloid cells; Medicine; Cancer research; Internal medicine; Biology; Genetics; Engineering; Signal transduction; MAPK/ERK pathway","score_opus":0.012591918784938701,"score_gpt":0.29009319149394197,"score_spread":0.27750127270900327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402785536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966445,0.0010815249,0.00060177717,0.000046067864,0.000005354875,0.000025297666,0.00086851715,0.000022997681,0.0007040358],"genre_scores_gemma":[0.9966768,0.00047758603,0.0009987153,0.00007850305,0.000008957387,0.000032164386,0.001401904,0.0000058813366,0.0003194613],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974376,0.000026988326,0.000032534954,0.00005538765,0.00009617503,0.00004516674],"domain_scores_gemma":[0.9997018,0.000046620127,0.00015019497,0.000015045181,0.000043594333,0.00004278091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014765517,0.00018318204,0.0002372052,0.0006348956,0.00020554614,0.00041625556,0.00012238692,0.00029921043,0.0012593685],"category_scores_gemma":[0.00034757782,0.00008970226,0.00016146387,0.00066226587,0.00021042813,0.00013944593,0.00026814465,0.00032223616,0.00034967755],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001327582,0.00007989209,0.1405576,0.00020792826,0.00006796856,0.00031679403,0.00013271566,0.00067467644,0.8383455,0.00014474288,0.00038115092,0.017763333],"study_design_scores_gemma":[0.000026069976,0.00077618955,0.844566,0.000044721713,0.00009959069,0.0033596368,0.00025586583,0.0028869004,0.14255594,0.00028920933,0.005120145,0.000019789803],"about_ca_topic_score_codex":0.00031710736,"about_ca_topic_score_gemma":0.0006970479,"teacher_disagreement_score":0.0012593685,"about_ca_system_score_codex":0.00024336553,"about_ca_system_score_gemma":0.00012437518,"threshold_uncertainty_score":0.0042129755},"labels":[],"label_agreement":null},{"id":"W4404524533","doi":"10.1007/s40268-024-00496-0","title":"In-Use Physicochemical Stability of Sandoz Rituximab Biosimilar in 0.9% Sodium Chloride Solution After Prolonged Storage at Room Temperature Conditions","year":2024,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sandoz Canada","keywords":"Relative humidity; Chemistry; Chromatography; Shelf life; Sodium; Humidity; Sodium dodecyl sulfate; Food science; Organic chemistry","score_opus":0.013969203204884036,"score_gpt":0.27798644947447765,"score_spread":0.2640172462695936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404524533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949227,0.0014191037,0.0021718352,0.000055638175,0.000029747136,0.000037989914,0.0003101115,0.000038083464,0.0010147586],"genre_scores_gemma":[0.9954389,0.00061305624,0.0017417208,0.00004164639,0.000013815072,0.000037231002,0.00051920355,0.00002018618,0.0015743902],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99941885,0.00012020757,0.000047485533,0.00010846745,0.00025649098,0.00004841453],"domain_scores_gemma":[0.9995415,0.000071006376,0.00015205615,0.000046270427,0.00015510252,0.000034018092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005629698,0.00029134005,0.00022597692,0.00017672425,0.00021106168,0.0004115057,0.000313789,0.00038116743,0.0015647857],"category_scores_gemma":[0.0009505941,0.00011347499,0.00027965932,0.00019389713,0.00022336651,0.00028446506,0.00024043188,0.00033321715,0.0004342435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035949695,0.000041959822,0.001547009,0.00006879032,0.000024396462,0.00008779975,0.00010978287,0.00018163634,0.9943175,0.000035861198,0.00011505575,0.0031107462],"study_design_scores_gemma":[0.0000138211135,0.001164916,0.010782394,0.000017612334,0.00007073755,0.00038508093,0.00010625214,0.0008024996,0.9838468,0.00004181894,0.0027426435,0.000025427344],"about_ca_topic_score_codex":0.00094946584,"about_ca_topic_score_gemma":0.0011027114,"teacher_disagreement_score":0.0015647857,"about_ca_system_score_codex":0.00033487924,"about_ca_system_score_gemma":0.0003009665,"threshold_uncertainty_score":0.0052346587},"labels":[],"label_agreement":null},{"id":"W4410829664","doi":"10.1007/s40268-025-00511-y","title":"Network Meta-Analysis of Pharmacological Therapies for Long-Term Prophylactic Treatment of Patients with Hereditary Angioedema","year":2025,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"CSL Behring","keywords":"Hereditary angioedema; Medicine; Prophylactic treatment; Term (time); Intensive care medicine; Angioedema; Meta-analysis; Dermatology; Internal medicine","score_opus":0.0998001851149383,"score_gpt":0.3768648895175485,"score_spread":0.2770647044026102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410829664","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031039672,0.95558256,0.005787963,0.0011500084,0.0008882141,0.00073069363,0.0031408253,0.00018686499,0.0014932948],"genre_scores_gemma":[0.8121486,0.1700946,0.0082966145,0.0016262972,0.00053202215,0.0023893316,0.003946731,0.00011539764,0.00085053395],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97355825,0.019819174,0.002736695,0.0018628765,0.0016253544,0.00039755405],"domain_scores_gemma":[0.9735005,0.020725433,0.0029623068,0.0014768078,0.0009791689,0.00035580035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02629382,0.0027747287,0.013068017,0.004773378,0.00053106935,0.0027748514,0.0022563287,0.0022194393,0.0043516443],"category_scores_gemma":[0.043314554,0.0012324455,0.049686074,0.004497709,0.00048146723,0.0015482354,0.0016700897,0.0022271392,0.00033053348],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034240952,0.000018149443,0.0042953203,0.025864543,0.9611236,0.000049812614,0.000017214812,0.0012229298,0.00008283821,0.00011571601,0.00039953177,0.0033862353],"study_design_scores_gemma":[0.0013648222,0.00019082511,0.0035189793,0.0018337338,0.990837,0.000049080903,0.000012016591,0.00096892344,0.000060850016,0.00037047168,0.00077749946,0.000015740234],"about_ca_topic_score_codex":0.007339313,"about_ca_topic_score_gemma":0.009600856,"teacher_disagreement_score":0.02629382,"about_ca_system_score_codex":0.0020255116,"about_ca_system_score_gemma":0.0022261094,"threshold_uncertainty_score":0.13905662},"labels":[],"label_agreement":null},{"id":"W4411554374","doi":"10.1007/s40268-025-00514-9","title":"Demonstrating Bioequivalence for a Lumacaftor Monosubstance Formulation Versus Orkambi® (Lumacaftor/Ivacaftor) in Healthy Subjects","year":2025,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ted Rogers Centre for Heart Research; Heart and Stroke Foundation; Micropharma (Canada); University of Toronto","funders":"","keywords":"Ivacaftor; Bioequivalence; Medicine; Pharmacology; Pharmacokinetics; Internal medicine","score_opus":0.031276308256390675,"score_gpt":0.38322318267005695,"score_spread":0.3519468744136663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411554374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952651,0.0009278646,0.0011749727,0.000078162455,0.0000844052,0.0008559121,0.0005738286,0.00004834149,0.0009913804],"genre_scores_gemma":[0.9961152,0.00028072647,0.0014626703,0.00012554566,0.0000639789,0.0004469345,0.0004486538,0.000014846961,0.001041441],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9983298,0.00094066415,0.000111438014,0.00030461754,0.00022113242,0.00009238799],"domain_scores_gemma":[0.9988846,0.00031574615,0.00039628526,0.00013742484,0.00012043401,0.00014554794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044029173,0.00042640945,0.0006350266,0.0002466191,0.0003123483,0.0005504314,0.00034781918,0.0010000379,0.0043197754],"category_scores_gemma":[0.0027313733,0.00021681759,0.00049767765,0.00022879314,0.0005074904,0.00037889896,0.00019250282,0.0006153352,0.0006764102],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.664363,0.016024377,0.014821375,0.0009915286,0.0011280235,0.00022772132,0.0007175023,0.00053742854,0.20422927,0.00046392283,0.0025978768,0.09389793],"study_design_scores_gemma":[0.05583523,0.69139993,0.17752075,0.00014227086,0.0017059671,0.0009956565,0.00035648368,0.0037192728,0.06088364,0.00028066206,0.0070715765,0.000088547495],"about_ca_topic_score_codex":0.00048112133,"about_ca_topic_score_gemma":0.0004881849,"teacher_disagreement_score":0.0044029173,"about_ca_system_score_codex":0.00029757607,"about_ca_system_score_gemma":0.00039867763,"threshold_uncertainty_score":0.02328515},"labels":[],"label_agreement":null},{"id":"W4411698938","doi":"10.1007/s40268-025-00515-8","title":"In-Vitro Comparison of Physical Characteristics, Enzyme Content, and Release Kinetics of Pancreatic Enzyme Preparations Available in Europe and Canada","year":2025,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Pancreatitis Pathology and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pancreatic enzymes; Enzyme; Enzyme kinetics; Kinetics; In vitro; Chemistry; Biochemistry; Food science; Physics","score_opus":0.016392243609865638,"score_gpt":0.27811217942217525,"score_spread":0.2617199358123096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411698938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98512,0.006369417,0.0011950318,0.00006400785,0.000021982127,0.00009073601,0.001709534,0.000020076222,0.0054092584],"genre_scores_gemma":[0.98498315,0.0042614127,0.0034679917,0.000113842565,0.0000097274415,0.000050109007,0.002814176,0.00003240734,0.0042670835],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99838877,0.00016698096,0.00015238844,0.00023489726,0.0008764429,0.00018056943],"domain_scores_gemma":[0.9989937,0.00015834019,0.00018036293,0.0000520629,0.00054713996,0.0000684444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009921815,0.0003083845,0.00033033817,0.00082523597,0.0004873052,0.0007991212,0.0003454379,0.00029071103,0.0012429168],"category_scores_gemma":[0.0013165966,0.00016089308,0.0004257705,0.0012615691,0.00042975196,0.00021665433,0.00035830052,0.0003089899,0.00020853942],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006080269,0.0005910645,0.07052725,0.0013787451,0.0005410836,0.0010330933,0.0011704037,0.0023539546,0.8508063,0.0006398319,0.0015130672,0.06336502],"study_design_scores_gemma":[0.00013418643,0.004097804,0.35695085,0.0002550488,0.0007253276,0.0013471439,0.0013336923,0.0032017375,0.60398424,0.000098893724,0.027765034,0.00010599139],"about_ca_topic_score_codex":0.3662506,"about_ca_topic_score_gemma":0.3623105,"teacher_disagreement_score":0.63374937,"about_ca_system_score_codex":0.0030948117,"about_ca_system_score_gemma":0.0032131195,"threshold_uncertainty_score":0.72823757},"labels":[],"label_agreement":null},{"id":"W4416599723","doi":"10.1007/s40268-025-00529-2","title":"Safety, Tolerability, Pharmacokinetics, and Viral Pharmacodynamics of the Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection in Participants with Early, Mild-to-Moderate COVID-19: A Randomized Clinical Trial","year":2025,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Intramuscular injections and effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada); Etobicoke General Hospital","funders":"GlaxoSmithKline Biologicals; Vir Biotechnology","keywords":"Pharmacodynamics; Monoclonal antibody; Randomized controlled trial; Intramuscular injection; Clinical trial","score_opus":0.02778996596572109,"score_gpt":0.4006819742762227,"score_spread":0.3728920083105016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416599723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99450135,0.0009767015,0.00035544793,0.00026327305,0.00011653205,0.0026482323,0.00034504992,0.000030056764,0.0007632959],"genre_scores_gemma":[0.99399275,0.0005198844,0.0008131743,0.00044277217,0.00020643415,0.002896845,0.0003429868,0.000009933022,0.00077531056],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99860746,0.0008661331,0.000096414486,0.00018646246,0.000100191544,0.00014331752],"domain_scores_gemma":[0.9980082,0.0005882696,0.0005668731,0.00017589825,0.00014205428,0.0005187653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003439643,0.001365039,0.0017215261,0.00032877133,0.0003877477,0.0008252233,0.00065863685,0.0018545381,0.004198997],"category_scores_gemma":[0.0029706256,0.00062862644,0.0018226997,0.00027199066,0.0012031507,0.0009323446,0.00034390896,0.002298674,0.00072038104],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97323924,0.011292587,0.0014056171,0.00022605213,0.00056971837,0.000024423245,0.000048384325,0.0001486236,0.0033444841,0.00006985432,0.00031150776,0.009319516],"study_design_scores_gemma":[0.73151684,0.2607321,0.004762831,0.000025930647,0.00062175153,0.000039284158,0.000026465295,0.00057404017,0.0009821242,0.00015737177,0.0005431258,0.00001813738],"about_ca_topic_score_codex":0.00032508047,"about_ca_topic_score_gemma":0.00058682275,"teacher_disagreement_score":0.004198997,"about_ca_system_score_codex":0.00069864973,"about_ca_system_score_gemma":0.0009112704,"threshold_uncertainty_score":0.018190801},"labels":[],"label_agreement":null},{"id":"W4416841363","doi":"10.1007/s40268-025-00530-9","title":"Safety, Tolerability and Pharmacokinetics of a High-Dose, Rapid-Infusion Monoclonal Antibody: Phase I Results for Intravenous Sotrovimab 3000 mg","year":2025,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"GlaxoSmithKline Biologicals; Vir Biotechnology","keywords":"Pharmacokinetics; Tolerability; Monoclonal antibody; Phase (matter); Phases of clinical research","score_opus":0.019543961811636652,"score_gpt":0.3693013937195685,"score_spread":0.34975743190793185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416841363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972791,0.000613703,0.0009905627,0.000109347115,0.000018714312,0.000424627,0.0002160288,0.00005449628,0.00029350596],"genre_scores_gemma":[0.9955539,0.00062455755,0.0019478514,0.0001741193,0.00005361439,0.0004399473,0.0005030032,0.000029997835,0.00067306537],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996749,0.00015576051,0.000016161666,0.000042681106,0.000059048853,0.000051455216],"domain_scores_gemma":[0.9994282,0.00011438868,0.00020860623,0.000058521717,0.00005518766,0.00013502981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010411211,0.0007068986,0.0007771423,0.00022268415,0.00019691109,0.00057572924,0.00062596594,0.0008031811,0.0017236328],"category_scores_gemma":[0.0009866689,0.00030885704,0.0007016038,0.00017404926,0.00047423725,0.00046880936,0.00013341403,0.0016854769,0.0004732228],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23601352,0.049982097,0.0105074635,0.00070845726,0.00077122677,0.00036029104,0.0005000906,0.004397095,0.549551,0.00021703177,0.0025350053,0.14445673],"study_design_scores_gemma":[0.13140656,0.73480713,0.043296576,0.000068156754,0.0006311262,0.0012718934,0.000086544605,0.005812259,0.078179926,0.00021317141,0.004165082,0.00006152994],"about_ca_topic_score_codex":0.00039391997,"about_ca_topic_score_gemma":0.00039782227,"teacher_disagreement_score":0.0017236328,"about_ca_system_score_codex":0.00045726774,"about_ca_system_score_gemma":0.00053122325,"threshold_uncertainty_score":0.0057661533},"labels":[],"label_agreement":null},{"id":"W8127528","doi":"10.2165/00126839-200708060-00003","title":"Improving Early Drug Discovery through ADME Modelling","year":2007,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":133,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"ADME; Drug development; Drug discovery; Drug; Risk analysis (engineering); Computer science; Pharmacology; Biochemical engineering; Medicine; Intensive care medicine; Bioinformatics; Engineering; Biology","score_opus":0.08703858291226216,"score_gpt":0.3781868798061028,"score_spread":0.2911482968938407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W8127528","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005326637,0.41576505,0.5584457,0.002621465,0.0011701524,0.0001394547,0.00047489768,0.00202148,0.014035123],"genre_scores_gemma":[0.07187828,0.6058687,0.30624327,0.0013868609,0.00095208763,0.00020412449,0.0011670846,0.00023809011,0.012061633],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9994469,0.0001489035,0.000032686494,0.00007343416,0.0002723216,0.00002572153],"domain_scores_gemma":[0.99871254,0.0008787114,0.00008744192,0.0001080698,0.00018647552,0.000026830086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015345928,0.0013690621,0.00236904,0.0011879837,0.00020787258,0.0007712848,0.002084325,0.0010631902,0.0026303388],"category_scores_gemma":[0.0023577083,0.0004978931,0.0010789355,0.001507348,0.00046435997,0.0012794366,0.0007731019,0.0019271886,0.0017194607],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014914351,0.00017363348,0.00025420083,0.0029900717,0.00023981309,0.00011219315,0.00001346854,0.054655004,0.0043749516,0.018139755,0.012247928,0.90664995],"study_design_scores_gemma":[0.00028768438,0.00083228596,0.00077314355,0.0014869454,0.00078813086,0.0019098932,0.000025667965,0.39122474,0.055503953,0.081125624,0.46591058,0.00013133748],"about_ca_topic_score_codex":0.0006507948,"about_ca_topic_score_gemma":0.0006787663,"teacher_disagreement_score":0.0026303388,"about_ca_system_score_codex":0.0005457191,"about_ca_system_score_gemma":0.0006221158,"threshold_uncertainty_score":0.008799434},"labels":[],"label_agreement":null}]}